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This dissertation focuses on the rational design of new class of functional
biomaterials using tools of nanotechnology to improve the unique functional
properties

of

proteins.

In

particular,

inorganic

layered

material,

!-

Zr(IV)phosphate (!-ZrP) was biofunctionalized by pre-adsorption of cationized
bovine serum albumin (cBSA), which act as a sacrificial protein, to promote
enzyme binding in a predictable manner. Enzyme/inorganic hybrids were
further characterized using various biophysical and bioanalytical tools to
evaluate the structural integrity, catalytic activity and the thermal stability of
bound enzymes. Enzyme binding to biofunctionalized !-ZrP (bZrP) indicated
exceptionally high loading and the binding is linearly proportional to the
number of residues present in the enzyme or its volume, providing a powerful,
new predictable tool for binding.
We also developed a simple, efficient and versatile method to synthesize
inorganic nanoparticles, as opposed to nanoplates described above, of welldefined

shapes,

controlled

size

and

defined

surface

functionalities.

Nanoparticles of a wide variety of materials such as proteins, nucleic acids,

i

Inoka K. Deshapriya, Ph.D., University of Connecticut, 2014
small organic molecules, metal complexes, inorganic solids and organic
polymers were prepared by controlled precipitation in a microscopic reactor,
which was rapid and highly reproducible.
The above studies were extended to synthesize highly stable, strongly
fluorescent, protein-based nanoparticles (Prodots), which are urgently needed
for nanomedicinal applications. Prodots in the size range of 15-50 nm were
prepared and they have been rapidly uptaken by human oral cancer cells.
Thus, they could serve as potential carriers for small molecules or for the
transport of biologically active proteins into cells, as alternatives to DNA
transfection studies.
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Chapter 1.

Nano-Bio

Interfaces:

Charge

Control

of

Enzyme/Inorganic Interfaces for Advanced Biocatalysis
1.1. Abstract
Specific approaches for the rational design of nano-bio interfaces for
enzyme and protein binding to nanomaterials are vital for engineering
advanced,

functional

nano-biomaterials

for

biocatalysis,

sensing

and

biomedical applications. This chapter presents an overview of our recent
discoveries on structural, functional and mechanistic details of how enzymes
interact with inorganic nanomaterials and how they can be controlled in a
systematic manner, using !-Zr(IV)phosphate (!-ZrP) as a model system. The
interactions of a number of enzymes having a wide array of surface charges,
sizes and functional groups are investigated. Interactions are carefully
controlled

to

screen

unfavorable

repulsions

and

enhance

favorable

interactions for high affinity, structure retention and activity preservation. In
specific cases, catalytic activities and substrate selectivities are improved over
those of the pristine enzymes, and two examples of high activity near the
water-boiling temperatures have been demonstrated. Isothermal titration
calorimetric studies indicated that enzyme binding is coupled to ionsequestration or release to/from the nano-bio interface, and binding controlled
in a rational manner. We learned that, (1) bound enzyme stabilities are
improved by lowering the entropy of the denatured state; (2) maximal loadings
are obtained by matching charge footprints of the enzyme and that of the
nanomaterial surface; (3) binding thermodynamics are controlled by ion
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sequestration at the nano-bio interface, and (4) maximal enzyme structure
retention is obtained by biophilizing the nano-bio interface with chemically
modified protein-glues. The chemical and physical manipulations of the nanobio interface are of significant importance not only to understand the complex
behaviors of enzymes at biological interfaces but also to design better
functional nano-biomaterials for a wide variety of practical applications.
1.2. Introduction
Enzymes bound to nanomaterials are being used extensively in advanced
biocatalysis,1,2,3 biomaterial4 and biomedical applications.5,6 This dissertation
describes recent investigations of enzyme binding to inorganic nanomaterials
and our current understanding of how to manipulate the nano-bio interface in
a predictable manner. Study of these interfaces is important to understand
fundamental biological processes such as enzyme binding to bone and teeth,
binding of the viral particles to host-cell surfaces prior to infection, cell
adhesion to solid surfaces and cell migration. These activities can contribute
to the fundamental understanding of nano-bio interfaces, and aid in the
development of rational approaches to control these interfaces for practical
applications or to engineer advanced biomaterials with predictable properties.
Most enzymes are proteins and they can be considered as complex, large,
well-defined, chiral organic molecules that often carry metal ions and water
molecules to maintain their enzymatic activities and/or structure.7 These
studies mainly focused on enzymes due to their remarkable role as highly
specific catalysts in living systems. They catalyze almost all chemical
reactions in the biological world, under ordinary conditions of aqueous
2

solutions, ambient pressures and physiological temperatures.8 These
reactions include hydrolysis,9 condensation,10 redox,11 isomerization,12
substitution,13 cyclization14 etc. Enzymes are the ultimate sustainable and
renewable green catalysts that are derived from earth-abundant, low cost
elements from biological feed stocks by production methods that are also
benign, renewable and sustainable. Therefore, enzymes are versatile,
promising candidates as industrial catalysts for the production of fine
chemicals, pharmaceutical intermediates, and drugs as well as for use in food
processing.
Use of enzymes outside the biological environment, however, has several
challenging limitations which include but not limited to: (1) high cost of large
scale production, separation and purification of enzymes; (2) their
susceptibility to deactivation under non-ambient conditions, organic solvents
and high ionic strengths; (3) they often have a very high specificity for a given
substrate and thereby making them ineffective toward even closely related
substrate analogs; and (4) they are difficult to recover from the reaction media
after the catalytic reaction.15,16 Therefore, lowering the cost, enhancing their
stability, broadening specificity and preventing their deactivation by organic
solvents are worthy, beneficial and challenging goals.
Enzymes bound to nanomaterials can overcome several of these
limitations. Enzyme stability, for example, has been improved by constraining
the enzyme between inorganic nanosheets17,18,19 and the high cost of
enzymes are obviated by re-cycling the solid-bound biocatalysts.20,21 Often,
enzymes bound to solids improved their enzymatic activities by more than
3

100%22,23 and solid-bound enzymes sustained activities at temperatures that
are close to the boiling point of water.24,25 The substrate specificity was
improved on contacting them with inorganic nanomaterials and expanding
their activity toward multiple substrates.26,27 However, there are no rational
approaches to tailor the nanobiocatalysts with desired improvements in
properties, and there are no qualitative or quantitative models to predict
enzyme behavior at the nano-bio interfaces. In this context, we began
systematic studies to evaluate the mechanism of enzyme binding to
nanomaterials and factors that control bound enzyme behavior. These data
are being used to develop rational approaches to control the nano-bio
interface and bound enzyme properties.
1.2.1. Enzyme Stability at the Nano-bio Interface – Thermodynamic
Constraints
The intrinsic stability of any enzyme is governed by the respective
thermodynamic states, that is, the free energy gap (∆Gd) between the native
state (N) and the corresponding denatured state (D). This gap is generally
positive for all enzymes, at room temperature and it decreases with increase
in temperature due to the increased contributions of the -T∆Sd term. ∆Gd
reaches zero at the denaturation temperature and enzyme denaturation is
spontaneous above this temperature. If the ∆Gd of the bound enzyme were
increased by interactions at the nano-bio interface, then bound enzyme would
be of greater stability than the corresponding pristine enzyme.
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That is, stabilizing the native state and destabilizing the denatured state
(SNSDDS) by the nano-bio interface is a powerful strategy. Since, the
equilibrium constant for enzyme denaturation (Kd) is exponentially related to
∆Gd, a small improvement in ∆Gd will provide significant gains in stability.
Since enthalpy change (∆Hd) is positive for enzyme denaturation, one obvious
approach to increase ∆Gd and stabilize enzymes is to decrease ∆Sd.
Our unique strategy to improve enzyme stability has been to lower ∆Sd by
lowering the entropy of the denatured state of the bound enzyme. Entropy of
any molecule depends on its conformational freedom (S = k ln #, where k is
the Boltzmann constant and # is the number of configurations that can be
populated by the molecule28) at a given temperature. Constraining the
conformations of the denatured state, therefore, would lower its entropy while
keeping the entropy of the native state the same. Thus, ∆Sd could be lowered
while raising ∆Gd, which should stabilize the enzyme.
We hypothesized that by intercalating the enzyme in the 2-dimensional
space of the galleries of layered inorganic materials, entropy of the denatured
state can be lowered, raising ∆Gd. Our approach, therefore, was to use the
nanoplates of the inorganic layered solid, !-Zr(IV)phosphate (!-ZrP) for
enzyme intercalation and test its stability.29,30 Although minimal or no protein
structural changes were observed in the cases discussed here, if there are
significant structural changes on binding to the solid, then the corresponding
free energy contributions need to be taken into account, and these aspects
are further discussed later. This report, therefore, reviews our various efforts
in controlling enzyme binding to !-ZrP and enhancing its stability by
5

constraining the conformational entropy of the corresponding denatured
states. First, we describe our approaches for enzyme intercalation (Scheme
1.1) and then, we describe specific examples as well as their degrees of
success in achieving the above goals, which ultimately resulted in benign,
protein-o-philic interfaces for enzyme loading.
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!-ZrP
Protein-polymer
conjugates

protein-polymer/cBSA/ !-ZrP

Cationized
BSA

TBAOH

exfoliated !-ZrP

Direct
Intercalation

protein/!-ZrP

A (85%)

E (90%)
C

on
ati

iza

n
tio

protein

Mn+

Metal assisted
Intercalation
Mn+

protein/!-ZrP

D (70%)

Mn+

Mn+
Mn+

Mn+

protein/Mn+/!-ZrP

protein/DNA/!-ZrP

B (65%)

C (70%)

Scheme 1.1 Approaches (A-E) for controlling enzyme binding to α-ZrP. Exfoliation
with tetrabutyl ammonium hydroxide (TBAOH) followed by: (A) direct binding of
positively charged enzymes, (B) metal ion-mediated binding of anionic enzymes, (C)
Hb-mediated binding of DNA/RNA, (D) cationization of enzymes to promote their
affinities, (E) protein-glues for the binding of enzyme-polymer conjugates. The %
retention of hemoglobin peroxidase-like activity is given in the parenthesis of each
approach (A-E).
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1.2.2. Layered Inorganic solid, !-ZrP
Layered !-Zr(IV)phosphate (!-Zr(HPO4)2.H2O, abbreviated as !-ZrP) was
chosen for a number of reasons. !-ZrP is a stable metal phosphate with a
layered structure (Figure 1.1).31,32 This solid and a number of its derivatives
were readily synthesized and purified in large amounts. Layered structure
accommodates enzymes of any size, from very small to very large,
monomeric to multimeric, globular, cylindrical or other shapes. Its high polarity
and hydration state allows the binding of cationic or anionic and water-soluble
globular enzymes, and it could preserve the native structure of the enzymes,
when compared to hydrophobic surfaces of other solids, which often denature
the bound enzyme. The large surface area of !-ZrP (100 m2/g) and its high
charge density33 of one negative charge per ~25 Å2 or -6.6 x10-6 mol/m2,
controls binding via electrostatic and other interactions. In comparison, solids
of lesser charge density, such as Montmorillonite with a charge density of 2.0x10-6 mol/m2 34, are expected to have weaker contributions of the charge to
the binding process.
Gallery spacing of the enzyme/!-ZrP intercalated materials are small
enough to protect the enzyme from microbial or protease degradations, but
they are wide enough to permit the diffusion of reagents and substrates into
and out of the galleries. The high residual charge of the !-ZrP nanoplates
provides a convenient handle to monitor enzyme binding by zeta potential
studies, and the layered structure provides an elegant method to test
intercalation by powder X-ray diffraction. The negative charge field and the
mechanical barrier offered by the nanoplates holds the intercalated biocatalyst
8

without leaching during catalysis. Therefore, covalent binding to the solid is
not required and the nano-bio interface can be readily manipulated to control
bound enzyme affinity, structure, loading and stability, as shown below.

i. Structure and Preparation of α-ZrP
A schematic structure of !-ZrP is shown in Figure 1.1A, which consists of
7.6 Å thick nanoplates made from a layer of Zr(IV) ions (open circles)
sandwiched between two layers of phosphate anions (blue spheres). Each
Zr(IV) ion is octahedrally coordinated by six oxygen atoms arising from three
different phosphates. The remaining OH group of each phosphate (pink
sphere) is oriented perpendicular to the metal plane, and !-ZrP nanoplates
hold very high charge density (maximum of one charge per 25 Å2) due to
weakly acidic OH groups with a pKa of ~7. !-ZrP nanoplates (Figure 1.1B)
stack into columns due to van der Waals interactions (Figure 1.1C-D). !-ZrP
was prepared by the addition of aqueous ZrOCl2 solution to phosphoric acid,
followed by reflux (24 h, 80 ˚C, equation 1)31,32 It is obtained as white dry
powder (40-50 % yield).30
ZrOCl2 + PO(OH)3 ! !-Zr(HPO4)2.nH2O…………………………(1)
1.2.3. Enzymes Examined and their Characteristics
Numerous

studies

describing

the

intercalation

of

ions,35,36

small

molecules,37,38,39 metal complexes40 and organic cations41,42 in the galleries of
!-ZrP are already reported.
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Figure 1.1 (A) Schematic structure of !-ZrP where OH groups (pink spheres) are
oriented perpendicular to the !-ZrP plane (open circles), (B) TEM image of individual
plates of !-ZrP taken by placing aliquots of 3 µL of 0.5 mM sample in DI on carboncoated Cu grid coated with 1 mg/mL BSA (C, D) SEM images of stacks of !-ZrP
contained an air dried suspension of 0.1 mM !-ZrP in 5 µl of DI on silica/Au plate.
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We have chosen a small set of representative enzymes with charges
ranging from +7 to -62 (Table 1.1). These represent a variety of sizes,
shapes, charge densities, isoelectric points (pI), different secondary/tertiary
structures, catalytic functions and stabilities.
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Table 1.1 Key features of enzymes used in this study

Enzyme/

pI

Property

Net charge

Hydrodynamic
Radius (Å)

Area of cross Molecular Wt.
section (Å2)a
(kDa)

Number of
residues

(pH 7)

Lys

10.9

7

19.8

1232

14.3

129

Cyt c

10.1

7

17.2

929

12.4

104

CHT

8.7

-1

20

1256

25

241

Mb

6.9

-4

20.4

1307

16.5

153

Hb

6.6

-8

32

3217

64.5

427

HRP

5.1

0

28

2463

44

308

GO

4.6

-62

40

5026

155

581

BSA

4.8

-18

33.7

3568

66.5

576

!-lactalbumin

4.5

-7

18.8

1110

14.2

123

Tyrosinase

4.3

-8

49.1

7574

128

1126

1.2.4. Enzyme Binding to !-ZrP Nanoplates
Binding of positively charged enzymes into !-ZrP nanoplates is expected
to be facile, because of favorable electrostatic interactions between the
enzyme and the anionic nanoplates. However, due to the very large sizes of
enzymes (30-100 Å), direct intercalation is kinetically very slow and does not
proceed at desirable rates. Hence, we considered exfoliation of !-ZrP stacks
prior to intercalation and exposing the nanoplates to the enzyme solutions for
successful binding.
1.2.5. Intercalation and Powder X-ray Diffraction
Exfoliation of the stacks of !-ZrP by treatment with a large cation such as
tetrabutyl ammonium (TBA) hydroxide was previously reported (Figure
1.2A),37 and we discovered successful binding of enzymes to exfoliated
nanoplates. Subsequent to binding, the enzyme-bound plates spontaneously
assembled to re-form stacks resulting in enzyme/!-ZrP intercalates.43
Enzyme intercalation is expected to increase the d-spacing between the
nanoplates upto the diameter of the intercalated enzyme, and intercalation
was established by powder X-ray diffraction data.43, 26 As expected, enzyme
binding resulted in strong X-ray diffraction patterns (Figure 2.3B) and new
peaks corresponding to the intercalated enzymes have been noticed. Peaks
of !-ZrP/TBA or pristine !-ZrP are no longer present in these patterns, which
clearly established enzyme intercalation between the nanoplates of !-ZrP. In
support of this conclusion, a plot of the observed d-spacings of the enzyme
intercalates vs average known size of the intercalated enzymes was linear
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(Figure 1.2C). The non-zero y-intercept of 6 Å for the linear fit has been
attributed to several layers of hydration at the nano-bio interface, and such
hydration is critical to maintain the native structures of the intercalated
enzymes.
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Figure 1.2 (A) Schematic representation of exfoliation of !-ZrP stacks using TBA for
enzyme binding and their re-assembly, (B) powder XRDs of the enzyme/!-ZrP
composite materials, the interlayer distances after protein intercalated in !-ZrP is
shown. (C) The correlation between the measured d-spacings of the protein/!-ZrP
samples and the corresponding sizes of enzymes estimated from the crystallographic
data,26 (D) The graph of Hb binding to !-ZrP: integrated heat released (closed dots)
and the best fit to the data (red line) measured by ITC.44
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1.2.6. Binding studies by isothermal titration calorimetry
Isothermal titration calorimetry (ITC) was used to investigate enzyme
binding to the nanoplates and ITC provides a direct measure of binding
enthalpies and binding stoichiometries, in a model independent manner.
When used with specific binding models, one could estimate binding
enthalpies, entropies, affinity constants and binding site sizes as well.
Energetics of enzyme binding to the nanoplates were measured by a
nanocalorimeter by adding aliquots (2-4 µL) of the protein solution (100 µM,
20 mM NaPipes pH 7.2, 1 mM TBA) to a suspension of !-ZrP (1 mM, same
buffer as protein solution) loaded into the calorimeter, till the binding was
saturated. The heat released or absorbed (Q) was monitored in real time and
analyzed using equation 2. From the known values of calorimeter volume
(Vo), the bulk concentration of the ligand (Xt), concentration of !-ZrP (Mt), the
binding constant (Kb), the binding site size (n), enthalpy of binding (∆H),
entropy of binding (ΔS) and the free energy of binding (ΔG) were calculated
by the single, identical binding site model. Goodness of fits and uniqueness of
fits were tested analytically.
2
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Titration of a solution of Hb into a suspension of exfoliated !-ZrP
!

nanoplates, for example, was accompanied by heat release (Figure 1.2D,
exothermic). The ITC data were fitted by single, non-cooperative, identical site
model and the best fit to the observed data (red line) indicated a binding
constant, Kb, of 2.4 ± 0.3 # 106 M-1 and binding site size of ~450 phosphates
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per Hb.44 The Kb and the binding site size obtained from ITC matched with
those obtained from centrifugation binding studies. This confirmed the validity
of the binding model and provided useful insight into the thermodynamics of
Hb binding. For example, exothermic binding is accompanied by significant
entropy loss (∆S = -50 kcal/Kmol) and origin of this loss is explained later in
this article. Next, we examined the structure and activities of bound enzymes.
1.2.7. Binding Capacity (loading) on !-ZrP
The loading of enzymes on nanoplates is limited by a number of attributes
of the nano-bio interface and loading is important in biocatalytic applications,
as higher loadings reduce bioreactor size and setup costs. Loadings of
various enzymes on !-ZrP have been measured by centrifugation binding
studies where the bound enzyme is separated from the free enzyme.
Maximal loadings obtained for enzyme/!-ZrP (g/g) with Lys, Cyt c, CHT,
Mb, Hb and GO were 1.4, 1.3, 1.9, 0.48, 2.25 and 0.44, respectively. These
loadings are much higher than normally noticed with other solid supports.
While positively charged enzymes (Lys, Cyt c) had higher loadings on
charged !-ZrP than those of negatively charged enzymes (Mb, GO), Hb
showed unusually higher loading, 2.25 (w/w). These loadings are used to
calculate the average areas occupied by the enzymes in the galleries of the
intercalated nanobiocatalyst. Cyt c binding studies, for example, indicated that
1 enzyme molecule occupied 435 phosphate groups on the !-ZrP nanoplate.
This loading translates to a footprint of ~100x100 Å2 per Cyt c, a value which
is much larger than the known area of cross-section of Cyt c (929 Å2).43 These
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data suggest that there are large distances between adjacent enzyme
molecules and such voids would facilitate the diffusion of reagents into or out
of the galleries. Such access to the bound enzyme is also essential for the
retention of intercalated enzyme activities. On the other hand, denaturation of
the bound enzyme would occupy larger area on the nanoplates, but such
denaturation would be easy to detect in spectral studies where the enzyme
structure can be readily monitored, as described below.
1.2.8. Bound Enzyme Structure
Enzyme-nanomaterial interactions often result in the distortion of the
bound enzyme structure,45 which are not desirable as these could result in the
deactivation of the enzyme. Structural changes of enzyme/!-ZrP samples
were monitored by infrared absorption (FTIR) and circular dichroism (CD)
studies. For example, amide vibrational bands (I, II and III) of enzymes are
highly sensitive to enzyme structural changes,46 and FTIR spectra of
enzyme/!-ZrP intercalates indicated extensive structure retention (Table 2).
The amide I/II bands of Mb/!-ZrP are nearly the same as those of Mb and
similar observations were noted for the other samples.
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Table 1.2 The amide I/II peak positions and helical contents from FTIR and CD
spectra.26

Enzyme

Amide I/II

CD bands (nm)

Free

Bound

Free

Bound

Hb

1654/1521

1653/1521

210/222

210/222

Mb

1651/1530

1651/1530

210/222

210/222

Lys

1650/1521

1650/1521

207/223

207/223

GO

1645/1538

1645/1538

210/218

210/218

Enzymes display a myriad of well-defined three-dimensional structures
built from a few secondary structural motifs. For example, α-helixes, β-sheets
and random coils dominate the structural elements of enzymes. These
structural details have particular CD bands. For example, !-helices show
strong positive peaks at 190 nm and medium intensity negative bands at 210
and 222 nm, while a broad negative peak at 212 nm is a characteristic of βsheets.47 Random coils result in a strong, sharp, negative peak at 195 nm.
Hence, the CD spectra are often useful to assess bound enzyme structure.48
The CD band positions of the above samples were examined and they
indicated extensive retention of native-like structures (Table 1.2) Such high
degree of structure retention is unusual, but bodes well for the retention of
enzymatic activities of these biocatalytic nanomaterials.
1.2.9. Improved Catalytic Activities
Retention of enzymatic activities of the enzyme at the nano-bio interface
has several stringent requirements such as: (1) substantial retention of the
active site structure; (2) good accessibility to the active site; (3) facile diffusion
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of the substrate to the active site and release of the product from the active
site into the solution, and (4) sufficient flexibility of enzyme structure such that
the active site can undergo conformational changes that are necessary for
catalytic activities. Conversely, activity studies probe subtle features of the
nano-bio interface of the bound enzyme and its active site structure, at the
molecular level.
Specific rates, Michaelis constant (Km) and maximum velocity of the
reaction (Vmax) were determined (Table 3) and all biocatalysts retained
significant activities with some of them showing higher activities than the free
enzymes. In the cases of GO/!-ZrP and CT/!-ZrP, for example, the activities
increased to 125 and 130% of the corresponding free enzymes, respectively.
On the other hand, activities of lysozyme, CHT and Mb intercalates have been
very close to those of the corresponding free enzymes. These observations
are remarkable, because enzyme binding to solid substrates often reduces
their enzymatic activities.49,50 Observed increase in the Vmax in the case of
Hb/!-ZrP and unchanged Km are favorable outcomes as well. When bound
enzyme structures are close to those of the unbound enzymes, biocatalysts
retain their native-like activities, but still higher activities are highly
desirable/possible.
The above activity data clearly demonstrate that diffusion of the substrate
to the active sites of the intercalated enzymes is facile. The retention of
native-like activities is essentially due to the extensive retention of their nativelike structures. While the above criteria ensure high activities, limiting the
value of Km is tricky and difficult, although an example is shown later. The
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structure retention, flexibility of the bound protein conformations, access to the
active site and release of the product into the solution are all important steps
in maintaining the bound enzyme activities.
Table 1.3 Specific activities, Km and Vmax of enzyme/!-ZrP intercalates. 26

Enzyme Specific Activity (µM-1 s-1)

Vmax (µM s-1)

Km (mM)

Free

Bound

Free

Bound

Free

Bound

Mb

3.3 # 10-3

2.0 # 10-3

1.4

1.6

0.08

0.04

Lys

11.0 # 10-3

9.4 # 10-3

0.5

0.5

0.63

0.63

Hb

1.3 # 10-2

3.8 # 10-2

0.103

0.112

0.0034

0.0042

CHT

3.1 # 10-1

4.0 # 10-1

–

–

–

–

GO

2.0 # 102

2.5 # 102

0.8

2.5

37

42

1.2.10.

Enhanced Substrate Specificity

Previous studies from our lab also assed the selectivities of the
intercalated biocatalysts, in one particular case. Most enzymes are specific to
one or few substrates and broadening the selectivity will be crucial for a wider
use in the laboratory or industry. On the other hand, some enzymes are nonselective

and

improving

their

selectivity

will

be

vital

for

selective

transformations. Mb, for example, is not an enzyme but it efficiently catalyzes
the oxidation of electron rich phenols by hydrogen peroxide and it has little or
no selectivity. The substrate specificities, rates of oxidation by Mb/!-ZrP and
Mb were determined with a number of ortho, para or meta isomers of
substituted phenols and ratios of these rates are given in Table 1.4. Values >1
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represent accelerated rates for the intercalated biocatalyst than the unbound
Mb, while values <1 indicates decelerated rates.
While unbound Mb did not discriminate between ortho and para methoxy
phenols for oxidation by hydrogen peroxide, Mb/!-ZrP catalyzed the oxidation
of the para isomer 2.5-fold faster than Mb, but it catalyzed the oxidation of the
ortho isomer 0.24-fold slower than the unbound Mb. Therefore, a 10-fold
increase in selectivity for the para isomer over the ortho isomer was noted for
Mb/!-ZrP, when compared no selectivity with Mb. The data obtained with
other derivatives of phenol also indicated that free Mb did not discriminate
between the ortho and para isomers, while Mb/!-ZrP oxidized para isomers
faster by a factor of 3-10, depending on the substrate used. The selectivities
are not due to differences in the redox potentials of the isomers (Table 1.4) or
due to the preferential binding of one of the isomers to the solid support.
Under the given reaction conditions (1-2 mM α-ZrP, 0-1 mM substrate), it is
unlikely that a substantial portion of one of the isomers preferentially binds to
the edge or the interior of the nanoplates, unless the binding constants for the
isomers differ greatly.
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Table 1.4 Relative rates of Mb/!-ZrP when compared to that of free Mb, with specific
substrates. Rates higher than 1 indicate increased rate for the bound Mb while the
ratio of one isomer to the other indicates the selectivity for one isomer vs the other.26

Substrate

Relative Rate
(bound/free)

Oxidation Potential/ V

p- methoxyphenol

2.54

0.406

o-methoxyphenol

0.24

0.456

phenol

1.26

1.04

o-cresol

0.31

0.556

aniline

0.97

0.70

m-aminophenol

1.75

-

o-aminophenol

0.09

0.124

The induction of specificity to an otherwise non-discriminating Mb was
attributed to distortions of its active site structure on binding to !-ZrP, where
the linear para isomer might fit well in the active site, while the curved ortho or
meta isomers are not readily accommodated. The free Mb, on the other hand
accommodates either of the two isomers readily. The selectivity studies show
that the nano-bio interface can have beneficial influence and it can potentially
alter the substrate selectivity of enzymes. However, binding can also disturb
the stability and improved stabilities are critical for biocatalytic applications,
which are discussed below.
1.2.11.

Enzyme stability – Differential Scanning Calorimetry (DSC)

Constraining the enzyme in the pseudo-2-dimensional space of !-ZrP was
predicted to improve its thermal stability by decreasing entropy of the
denatured state, while leaving the entropy of the native state unchanged. This
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is because the Gibbs free energy is a function of enthalpy and entropy (ΔG =
ΔH – TΔS) at any temperature. Therefore, when ΔH is constant, ΔG solely
depends on ∆S and according to SNSDDS, when ∆S is lowered, higher
temperature is required to denature the enzyme. Hence, the stability of the
enzyme could be improved. DSC provides a direct measure of enthalpy of
denaturation (ΔHd), the denaturation temperature (Tm) and heat capacity
change accompanying the denaturation process (ΔCp) in a model
independent manner. When denaturation is reversible, ΔGd and ΔSd could
also be determined using particular denaturation models.
The DSC thermograms of intercalated enzymes showed extensive
broadening, and denaturation continued well beyond the corresponding Tm of
the free enzyme. Thus, a fraction of intercalated enzyme was found to be
more stable than the corresponding free enzyme, in almost every case.51
Extensive broadening of the thermograms could be due to conformational
heterogeneity, multipoint contact of the enzyme with the solid, heterogeneity
in the population of the binding sites, multi-step kinetics of denaturation or/and
enzyme aggregation. Thus, DSC data analysis is complicated, but a
significant fraction of the intercalated enzyme had higher ∆Hd (Figure 1.3A,B).
Since a portion of the bound enzyme denatured well above the Tm,17 and ∆H
increased, ∆S must have decreased. This was predicted for enzymes
constrained between the nanoplates. Unfortunately, the denaturation was not
reversible and we could not directly confirm this conclusion, but these data
suggested that the biocatalysts could be active at elevated temperatures,
which is presented below.
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1.2.12.

High Temperature Catalysis

Encouraged from the highly preserved enzymatic activities of enzymes
bound to !-ZrP and improved denaturation enthalpies in DSC studies, we
tested the high temperature activities of selected systems. For instance, the
high temperature activity of HRP/!-ZrP at 86 ºC and the peroxidase-like
activity of Hb/!-ZrP at 90 ºC are tested. The specific activity of HRP/!-ZrP is
doubled at 86 °C and the specific activity of Hb/!-ZrP is increased by a factor
of 3.6 at 90 °C, when compared to the corresponding specific activities at
room temperature (Figure 1.3C,D). In contrast, unbound HRP and Hb are
rapidly deactivated at the corresponding elevated temperatures. The Km and
the Vmax are also estimated from the activity data collected at 90 °C, at several
substrate concentrations. Thus, Vmax is increased 3.2-fold by increasing the
temperature to 90 °C, while there was a 20% decrease in the Km, indicating
rate accelerations with enhanced substrate binding. The activities of HRP and
Hb at elevated temperatures illustrate improved thermal stabilities of the
intercalated proteins. The principle of SNSDDS applied with the inorganic
matrix can account for the enhanced high temperature activities of the bound
enzymes.
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C

D

Figure 1.3 Thermal denaturation parameters (A) ΔH of denaturation and (B)
denaturation temperature (Tm) of bound proteins (red) and unbound (blue) proteins
measured by DSC.51 !-ZrP concentration in every case was kept at 3 mM and all the
samples were prepared and ran in 10 mM K2HPO4 buffer, pH 7.2) (C) Peroxidase
activity of HRP/!-ZrP (blue) and HRP (red) at 90 ºC (D) Lineweaver-Burk plot for
Hb/!-ZrP at 86 ºC.
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1.2.13.

Mechanism of Enzyme Binding

An important question in this field is, how does the enzyme binds to the
nano-bio interface and what interactions govern this process?
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Binding is

controlled by multiple factors such as temperature, ionic strength and
protonation or de-protonation and a number of molecular interactions. We
previously examined binding thermodynamics of a small set of enzymes to
evaluate these factors and interactions that influence the binding events.
1.2.14.

Enzyme Charge and Binding Enthalpies

Binding of a small set of enzymes was quantitated by ITC, and the
corresponding binding enthalpies and entropies have been evaluated as a
function of enzyme charge (Table 1.5). Overall, binding constants of this small
set of enzymes varied over three orders of magnitude, and at first glance,
there has been no clear correlation between the binding affinities vs enzyme
charge, pI or other properties of these enzymes.
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Table 1.5 Binding parameters for a small set of enzymes with !-ZrP (298 K, NaPipes).53

b

Enzyme

Kb /106M-1b

∆H/(kcal/mol)

∆S/(kcal/K.mol)

-∆G/(kcal/mol)

Lys

150 ± 7, 5 ± 1

2.3 ± 0.9, 60 ± 40

45 ± 4, 230 ± 130

11 ± 0.3, 10 ± 1

Cyt c

180 ± 10

18 ± 1.0

98 ± 10

11.3 ± 0.4

Hb

2.3 ± 0.3

-24 ± 2

-50 ± 0.1

9 ± 1.0

Mb

3±1

-14 ± 1

-20 ± 4

9.0 ± 0.4

Tyrosinase

800 ± 400, 150 ± 150

-13 ± 0.4, 25 ± 4

-44 ± 55, 120 ± 20

12 ± 0.4, 10 ± 1

from ITC studies; c ∆S was calculated using the relation DG = DH - TDS; d 20 mM NaPipes, 1 mM TBA pH 7.2.

The above binding data from ITC measurements, however, showed strong
trends with respect to enzyme charge. For example, the binding of negatively
charged enzymes to the negatively charged !-ZrP was exothermic, contrary
to expectations based on simple electrostatic models. Similarly, the binding of
cationic proteins was endothermic, again contrary to expectations of favorable
interactions between oppositely charged surfaces. Thus, processes that are
not readily evident contribute to these values to a significant extent. A plot of
∆H against enzyme charge showed correlation (Figure 1.4A) with some
notable exceptions and began providing some clues.
The deviations observed from the linear plot, in the case of Hb and BSA,
could be due to additional enthalpy contributions emanating from enzyme
structure distortion when they bind to the nanoplates, or that these bind in a
preferred orientation where the interface has a higher or lower charge than
anticipated from overall charge. The slope of linear fit to the ∆H data indicated
binding enthalpy of 1.18 kcal/mol per unit charge and the sign of ∆H changed
with the change in the sign of enzyme charge.53 The slope is close to the
molar binding enthalpies of protons and sodium ions with !-ZrP (1-2
kcal/mol), which strongly suggested that proton-coupled or cation-coupled
enzyme binding dominates the binding enthalpies.
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A

B

C
binding to anionic solid

cationic protein

D
binding to anionic solid

anionic protein

Figure 1.4 Plots of (A) binding enthalpy and (B) binding entropy vs net charge
(electrostatic unit of charge) of the enzyme, at pH 7.2 measured by ITC. In each case
2-4 µL of 50-100 µM proteins were injected into 1 mM !-ZrP suspension in 20 mM
NaPipes, 1mM TBA pH 7. The slope of the ∆H plot is 1.18 kcal/mol per unit charge.
The error bars are smaller than the size of the symbols used in the graph.53 (C), (D)
The proposed mechanism for enzyme binding to !-ZrP where enzyme binding is
dominated by release or sequestration of counter ions from/into bulk solvent (counter
ions are represented by small red and blue spheres). Figure adapted from ref.44
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The overall binding enthalpy with !-ZrP can be described in terms of
specific,

multiple

contributions

to

the

enthalpy

which

include:

(1)

conformational changes ("Hconf), (2) co-intercalation of ions at the enzymesolid interface ("Hion), (3) protonation and de-protonation of the interface
("HH+), (4) changes in the hydration status of the interface ("HHydration), (5)
electrostatic interactions between the enzyme and the solid surface ("Hel).
However, !-ZrP is a rigid, inorganic solid and it should have little or no
contributions from conformational changes of the framework toward enzyme
binding. The CD and IR spectra of the proteins bound to !-ZrP showed that
bound enzyme conformation changes are also minimal. Hence, ∆Hconf may be
set to zero. The other terms were evaluated by examining ion binding/release,
proton uptake/release, temperature and ionic strength dependence studies,
elaborated later.
Similar to enthalpies, binding entropies showed a strong trend with
enzyme charge (Figure 1.4B, R2 = 0.99) than the enthalpies, but there was no
correlation between ∆S and the pI of the enzyme, number of charged groups,
number of hydrophobic or hydrophilic residues on the enzyme. The slope of
∆S plot was +6.1 cal/K.mol per unit charge, ∆S increasing sharply with
enzyme charge. The ∆Sobs was also parsed, as in the case of ∆H. The ∆S
associated with the loss of translational and rotational motion ("Smotions) when
enzyme is parked on the solid surface and loss due to the burial of side
chains at the interface are to be taken into account. But these are quite small
and set to zero. The change in the conformational entropy, "Sconf, can be
significant if the protein is denatured on binding to the solid. But in our
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examples, this has been very minor and also set to zero. Hence, "Sobs = "Sion
+ "Ssolvent and "Sion is proportional to the number of ions released/adsorbed
from/to the protein-solid interface during the binding process. The remaining
term, "Ssolvent arises from the fact that surfaces that are brought together
during the binding process undergo hydration and/or dehydration. This term
becomes important when hydrophobic interfaces are involved but can also be
significant with hydrophilic surfaces such as the metal phosphates.
The observed trends in the ∆H and ∆S values are counter intuitive, but
they were explained by proposing that binding to the nano-bio interface
involves counter ion release or sequestration (ion-coupled protein binding
(ICPB) model, Figure 1.4C,D). In detail, binding of positively charged enzymes
(Lysozyme and Cyt c) to the negatively charged solid release cations/protons
from the interface, where the cationic enzyme serves as a counter ion for the
solid and solid serves as the counter ion for the enzyme. This mechanism
maintains charge neutrality at the nano-bio interface and contributes to
positive values of ∆H and ∆S, which indicates that binding of oppositely,
charged species is entirely entropy driven (Figure 1.4C).
Using this principle of charge-neutrality of the nano-bio interface, one
would predict that the binding of negatively charged enzymes (Hb, tyrosinase
and Mb) to the negatively charged solid would require sequestration of
cations/protons at the enzyme-solid interface (Figure 1.4D). This process is
expected to be exothermic, as this involves the binding of cations at a strongly
negatively charged interface and it will be accompanied by negative entropy
changes as ions are being sequestered from the solution to the interface.
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These expectations are consistent with the above observations and the
binding of anionic enzymes to the anionic solid is entirely enthalpy driven.
Thus, ICPB mechanism appears to account for the thermodynamic data
reported above.
For the first time, a clear mechanism for the binding of enzymes to
charged solids has been proposed and verified by rigorous thermodynamic
data, and it postulates that charge neutralization of the nano-bio interface is a
major driving force. The fundamental principle that was learned is that simple
electrostatic model for enzyme binding is not valid, as enzymes are not point
charges. Charged residues at the interface need to be accommodated with
minimal repulsion or maximal attraction, as dictated by the nature of the
interface and ions present in the medium. This model was supported by a
number of systematic studies described below.
1.2.15.

Temperature Dependence

To evaluate the role of solvent in the binding events, ∆Hb was measured
as a function of temperature, and the resulting values of heat capacity
changes (∆Cp) indicate solvent participation in the binding process. Plots of
∆Hb vs temperature for Hb, Mb and lysozyme indicated positive ∆Cp values of
1.4 ± 0.3, 0.89 ± 0.2 and 0.74 ± 0.1 kcal/(mol.K), respectively. Positive ∆Cp
values are typically ascribed to the exposure of nonpolar groups to the solvent
or the burial of polar groups.54 The ∆Cp values showed very strong correlation
with the total number of positively charged groups (lysines and arginines) on
the enzyme surface but not with enzyme charge, or total number of charged
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groups, or hydrophobicity or the surface area of the enzyme. Hence, this
analysis confirmed that binding is governed by positively charged side chains
present at the interface but not net charge other physical or chemical
properties. Burial of these charged groups at the interface would require
charge neutralization by ions, which is consistent with the ICPB model.
1.2.16.

Ionic Strength Dependence Studies

Since positively charged residues play a key role in the binding process,
their contributions are evaluated by measuring ∆H as a function of ionic
strength. As the ionic strength increased by the addition of sodium chloride,
the magnitude of ∆H decreased and this trend is consistent with the increased
screening of electrostatic interactions at higher ionic strengths. Analysis of the
data using the polyelectrolyte theory showed that the enthalpy depended on
ionic strength as 20.8 ± 2.9 (Hb), 3.4 ± 0.6 (Mb) and -3.9 ± 1.4 (lysozyme)
kcal/mol per ln([Na+]). Thus, electrostatic contributions to Hb binding is
significant, even though it is nearly neutral at pH 7 and hence, we suspect that
Hb binding might be accompanied by protonation of a large number of
lysine/carboxylate groups present at the nano-bio interface. In other words,
Hb binding is likely coupled with proton binding to off set the strong negative
charge of the !-ZrP surfaces. Thus, Hb binding is expected to depend on pH,
consistent with the ICPB model.
1.2.17.

Buffer Ion Dependence Studies

The hypothesis of proton-coupled protein binding was further tested by
measuring ∆H as a function of ionization enthalpies of different buffers ions, at
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constant ionic strength, temperature and pH. The ∆H for Hb binding to α-ZrP
decreased with increasing buffer ionization enthalpies and Hb binding resulted
in proton absorption at the interface. On the other hand, the binding of
positively charged Lysozyme to !-ZrP had negligible effect on proton release
or

sequestration.

Thus,

the

observed

∆H

included

buffer

protonation/deprotonation as well as enzyme protonation/deprotonation, ion
binding/release as well as burial of polar groups at the nano-bio interface.
Thus, charged groups have a major impact on the observed thermodynamic
properties and spectator ions/solvent play an important role in the binding
events.
1.3. Building on the ICPB Model
The ICPB model was exploited to control enzyme binding to α-ZrP.
According to the ICPB model, for example, binding of negatively charged
enzymes to !-ZrP is accompanied by the sequestration of cations at the
enzyme solid interface, so that excess negative charge at the interface is
balanced. This proposition predicts that metal ions that have a high affinity to
the solid should promote the binding of the anionic enzymes.55 Thus,
particular metal ions are predicted to serve as excellent metal-glues (Figure
1.5A) for the binding of anionic enzymes to !-ZrP.
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Figure 1.5 (A) Schematic representation of metal-ion mediated binding of anionic
enzymes to !-ZrP, (B) Maximal binding of GO (20 μM) and Hb (80 μM) to α-ZrP (3
mM) as a function of specific metal ions (1 mM, pH 3), as marked (Cr(III) data
corrected for a small amount of enzyme precipitation).55
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1.4. Modulation of Enzyme Binding with Metal Ion-glues
A number of metal ions were tested for their ability to function as metalglues to bind enzymes to !-ZrP, as predicted by the ICPB mechanism (Figure
1.5A). The influence of metal ions was expected to depend on metal ion
charge and ions with greater charge are expected to provide higher
stabilization of the anionic interface than the ions with lower charge. In
addition, the affinity of the metal ion to the specific functional groups present
at the interface is also to be taken into account. This is because, the ICPB
model predicts that the net gain in the energy due to metal ion binding to the
interface determines the overall affinity of the enzyme, and this energy gain
could be due to electrostatic interactions, coordination of the metal ions to the
functional groups of the enzyme as well as the solid. For example, ions that
are strongly phosphophilic would be of greater value in promoting binding to
!-ZrP when compared to those that have poorer affinity. Similarly, metal ions
that have a high affinity for the surface functional groups of the enzyme are
expected to improve the binding.
For these studies, we chose the strongly anionic GO (pI = 4.6) with 62
negative charges at neutral pH and strongly anionic Hb (pI = 6.8) with just 8
negative charges. The prediction was that the metal ions should have
substantial influence on the binding of GO but not on Hb. Since GO is strongly
negatively charged (-62 charge), it has very weak affinity for anionic !-ZrP
and we tested the influence of Zr(IV), Cr(III), Zn(II), Ni(II), Mg(II), Ca(II),
Au(III), H(I) and Na(I) on GO binding (Figure 5B).
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Zr(IV) improved the binding of GO from 5% to 90%, at moderate
concentrations of the metal (1 mM Zr(IV) (Figure 5B), and metal mediated GO
binding showed the trend Zr(IV) > Ca(II) > Cr(III) > Mg(II) >> H(I) > Na(I).
Therefore, metal ion charge is not the only factor controlling its ability to
promote GO binding to !-ZrP. Coordination of metal ions to the surface
carboxyl groups of the enzyme and the phosphate surface groups of the solid
also played a major role. For example, Zr(IV) is by far the most oxophilic and
phosphophilic among these,56 and it promoted the binding the most, followed
by Ca(II) and then Cr(III). Ca(II) was much more effective than Mg(II), since
Ca(II) is more oxophilic than Mg(II).
In contrast to the strong improvements of GO binding by metal ions, the
binding of Hb, which has fewer COOH groups on its surface than GO,55
improved only marginally. It increased from ~80 to ~97% by the addition of 0.5
mM Zr(IV), and surprisingly, higher Zr(IV) concentrations inhibited Hb binding.
This latter observation was attributed to the requirement that the metal should
bind to both the protein as well as the solid with high affinities, but if it binds to
!-ZrP better than to the enzyme, then enzyme binding may be inhibited.
Interestingly, Zr(IV) enhanced the maximal loading of Hb from 225% to 400%
(w/w), making it one of the highest loadings noted for a biocatalyst. Hb binding
followed the order Zr(IV) > H(I) > Mg(II) > Na(I) > Ca(II) > Cr(III), showing the
importance of chemical nature of the ion rather than its charge as the
governing factor for the metal glues. H(I) was more effective in promoting Hb
binding α-ZrP than the trivalent Cr(III) or the divalent Ca(II) (Figure 1.5B),
which is consistent with the buffer ion dependence studies described before.
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Therefore, the effect of metal ion depends on its ability to bind to the nano-bio
interface than just to the solid or to the enzyme surface. This conclusion is
consistent with the ICPB model, and the ensuing thermodynamic effect is
more than electrostatic. However, careful selection of metal ion is required
due to the inherent risks of certain metal ions that could inhibit enzyme
activities,57 but !-ZrP might compete for these ions and weaken such
inhibition.
1.5. Proteins as Soft Counter Ions
Along the above lines of deduction, the ICPB mechanism also predicts that
proteins bind strongly to the solid as well as the biomolecule of interest could
serve as protein glues. This aspect was tested,58 where Hb served as a glue
to bind anionic DNA and RNA to !-ZrP (Figure 1.6A).
Anionic DNA and RNA have only weak affinities for anionic !-ZrP, but the
presence of suitable proteins that bind to the DNA/inorganic interface should
promote binding (Figure 1.6A). The addition of Hb to a mixture of calf thymus
DNA (80 µM) and exfoliated !-ZrP (6 mM) promoted DNA binding as a
function of increasing Hb concentration (Figure 1.6B) and binding of DNA
indicated a bell-shaped curve as a function of Hb concentration. DNA did not
bind to the solid in the absence of Hb, and >1 nmol of DNA was bound per
every 100 nmol of !-ZrP. This approach of using Hb as a glue provided a
facile method to intercalate various nucleic acids in the inorganic layered
materials, which is not otherwise possible.
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The Hb/DNA/!-ZrP ternary complex was characterized by SEM, TEM,
XRD, CD and activity studies. The SEM and TEM micrographs indicated 48 ±
1 Å spacing between the nanoplates and this value was verified by powder
XRD measurements which indicated a d-spacing of ~ 40 Å (data not shown).
Unexpectedly, intercalation of DNA improved Hb structure retention as well as
its catalytic activities, when compared to that of Hb/!-ZrP. The CD spectrum
of Hb/DNA/!-ZrP, for example, was nearly indistinguishable from that of Hb.58
The peroxidase like activity of Hb/DNA/!-ZrP steadily increased as a function
of DNA concentration to a maximum of 1.6x107 s-1 per molar Hb (Figure
1.6C), much greater than that of Hb/!-ZrP, under the same conditions of pH,
temperature and substrate concentration.58 Similar observations were noted
when Hb was replaced by Mb. Thus, Hb and Mb served as protein glues to
improve the binding of DNA to !-ZrP, while DNA served as an unusual cointercalant to enhance the behavior of Hb and Mb. Biological counter ions,
thus, appear to be excellent to improve enzyme affinities and activities at the
nano-bio interfaces.
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Figure 1.6 (A) Schematic representation of Hb-mediated DNA binding to !-ZrP. (B)
Binding isotherm of DNA (80 µM) as a function of changing concentration of Hb and
!-ZrP concentration at 6 mM. (C) Enhanced activity of Hb/DNA/!-ZrP (Hb, 7.7 µM,
DNA 30 µM and !#ZrP 6 µ$) when compared to Hb/!-ZrP in the absence of DNA,
The peroxidase-like activity of Hb and all complexes were carried out with 5 mM
H2O2 and 12.5 mM guaiacol in Tris HCl buffer.
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1.6. Control of Enzyme

Binding Via Charge

Tuning: Chemical

Modification
The ICPB model predicts that enzyme binding to !-ZrP depends on the
number of charged residues on the enzyme surface and not necessarily net
charge on the enzyme. So, we systematically engineered positively charged
side chains on enzyme surfaces via chemical modification (Figure 1.7A) and
tested their binding behavior.59 In simple terms, positively charged groups
placed at the nano-bio interface could enhance enzyme binding. This
hypothesis was tested by introducing polyamine chains on enzyme surface
via chemical modification and testing the binding affinities of the modified
enzymes.
Amidation of the enzyme surface COOH groups with polyamines converts
them into the corresponding amide-polyamines, thereby neutralizing the
negative charge of the ionized COOH group and also by providing additional
protonatable amino groups. Depending on the pH of the medium, the charge
could potentially change from -1 to +n for each amidation event, with a
maximum change of charge by n+1 electrostatic units. Furthermore, enzyme
charge can be adjusted by a wide range, via controlling the extent of
amidation, as desired.
The COOH groups of negatively charged GO (pI 4.6) and Hb (pI 6.8), for
example, were chemically modified with tetraethylenepentamine (TEPA) by
EDC chemistry to obtain enzyme charge ladders (Figure 1.7B).53 Progress of
chemical modification was followed by agarose gel electrophoresis in which
the unmodified anionic enzymes moved toward the positive electrode while
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the cationized enzymes moved toward the negative electrode (Figure 1.7B).
The cationized samples were named based on the enzyme, polyamine and
net charge. GO-TEPA(+20), for example, indicated GO modified with TEPA
with a net charge of +20. The chemical modification and charge reversal was
also confirmed by mass spectrometry, and these samples provided an
excellent means to test the ICPB mechanism.
Binding studies with GO-TEPA(+20) (50 µM) indicated that the amount of
GO-TEPA bound is much greater than that of GO (Figure 1.7C), under the
same conditions of pH, temperature, ionic strength and !-ZrP concentration.53
Analysis of the binding data indicated kb = 1.1± 0.2 % 107 M-1 which is 400times larger than that of GO, demonstrating the strong role of charged
residues at the nano-bio interface. Hb-TEPA(+16), on the other hand, showed
26-fold increase in affinity for !-ZrP (kb = 1.4 % 107 M-1) when compared to
that of Hb (kb = 4.4 % 105 M-1), under the same conditions of pH, ionic strength
and temperature. These observations support the hypothesis that by inserting
additional positive charges or polar groups at the nano-bio interface can
enhance affinity by orders of magnitude, consistent with the predictions of the
ICPB mechanism.53
Enhanced binding was also achieved without significant loss of enzyme
structure or activity. The CD spectrum of GO-TEPA/!-ZrP showed only 1520% loss in structure when compared to that of pristine GO (Figure 7D) but
much greater than the corresponding GO/!-ZrP.59 Activities of GO-TEPA/!ZrP samples showed ~2.5-fold improved activity when compared to that of
GO/!-ZrP, while Hb-TEPA/!-ZrP retained 76% of Hb activities (Figure 1.7E).
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Hence, the ICPB mechanism provided useful insights to control and improve
affinities in a systematic manner, without compromising their activities.
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Figure 1.7 (A) Enzyme cationization to enhance binding, (B) Agarose gels of proteinTEPA conjugates. Lane 1 contained GO, while lanes 2 and 3 contained GO-TEPA (4
h reaction) and GO-TEPA (12 h reaction), respectively. Lane 4 contained Hb while
lanes 5 and 6 contained Hb-TEPA (8 h reaction) and Hb-TEPA (12 h reaction),
respectively. (C) Scatchard plots for GO and GO-TEPA binding to α-ZrP. (D) CD
spectra of GO, GO-TEPA and GO-TETA/ α-ZrP (E) Comparison of enzyme activities.
53
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1.7. Concluding Remarks
The major question in this field is, how to predict the properties of an
enzyme residing at a given nano-bio interface? The enzyme properties of
interest are affinity, structure retention, activity and thermal stability. The
above studies show that binding enthalpies and entropies of many enzymes
!-ZrP can be predicted from enzyme charge. The binding enthalpies and
entropies can be combined to predict the binding affinities (∆G) with a
reasonable measure of confidence. Given the issues of enthalpy-entropy
compensation for enzyme binding and the contributions of enzyme structure
loss to the observed enthalpies, the overall affinities of enzymes may not be
accurately predictable from their net charge. Therefore, we conclude that
systematic thermodynamic studies can be powerful predictive tools for
affinities. There may be other indicators that can predict enzyme affinity but
presently, there are no known methods of such prediction, experimental or
theoretical.
Another major conclusion is that the fundamental basis for this
thermodynamic control is the basic requirement of charge neutralization, when
the surfaces are electrically charged. That is, when the two surfaces meet
during the binding process, the charge density on the guest surface needs to
match the charge density of the host surface, and this charge matching
requires either release of ions or recruitment of ions of appropriate charge,
number and affinity. Thus, binding affinities could be systematically controlled
by the nature and extent of ions present in the solution. When the charge
density on the enzyme matches with that of the nano-sheets, the binding is
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still governed by ICPB mechanism, since each charged surface carries
counter ions. However, when there is a charge-mismatch, greater numbers of
ions will be involved in the mechanism. This is because the mismatch requires
release or sequestration of additional ions.
The ICPB mechanism provided excellent control over enzyme affinities
via the control of the concentrations and compositions of other participating
species that are present. Using this insight, we were able to drive the
intercalation of nucleic acids and other anionic proteins into the anionic !-ZrP,
which is otherwise not possible. These led to the discovery of metal-glues and
later, protein-glues and polymer-glues, for enzyme binding to !-ZrP.
We suspect that metal-glues, where the metal ion drives the binding could
provide a strong, predictable approach to control affinity. Along these lines,
the discovery of protein-glues and polymer-glues are of major importance and
provide powerful strategies to control enzyme binding, as well as the retention
of bound enzyme structure at the nano-bio interface. For example, Hb has
high affinities to both DNA and !-ZrP, and these facts provided an opportunity
to use Hb as a glue to bind nucleic acids to !-ZrP. This tactic provided an
excellent avenue to enhance the binding of anionic guests to the anionic !ZrP with retention of enzyme structure and activities.
Inspired by the above approach, it is hypothesized that when a sacrificial
protein is properly modified, it could serve as a protein-glue to bind an
enzyme of interest to a particular solid with high affinity and structure
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retention. This hypothesis was tested using cBSA as a protein-glue and
discuss in detail in the next chapter.
Although these studies are focused on !-ZrP, the physical insights are
applicable to other nano-bio interfaces, however this needs to be tested in
future studies. Using these methods, one could envision the biophilization of
nanomaterials for the binding of anionic or cationic enzymes with a high
degree of predictability/control. Above studies show successful intercalation of
ten different enzymes and proteins in the galleries of !-ZrP. In addition, we
also examined carboxymethyl and carboxypropyl analogs of !-ZrP for protein
binding and biocatalysis, which are not discussed here. Majority of these
bound enzymes have indicated significant retention of structures and
activities, and some indicated improved selectivities,26 and recyclability.62 In
general, these inorganic solids appear to be benign for enzyme loading and
provided biocatalysts with improved properties. One potential approach to
enhance biocatalytic activities further would be to intercalate two or more
enzymes that work in tandem, speeding-up the overall rates. This is yet to be
tested systematically.
Inorganic materials continue to have a high impact on enzyme loading,
bioreactors and biomaterials that come in contact with proteins or enzymes.
The thermodynamic and kinetic arguments provided here should also be
applicable to any other solids such as metal phosphates, oxides,
semiconductor, graphitic and related materials. The primary reason for this
expectation is that the above principles of enzyme binding and manipulation
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of the enzyme/inorganic interface does not rely on the molecular structure of
!-ZrP, rather its charge, layered topology and hydrophilic nature.
One critical advance required would be to quantify the influence of lower
dimensions of space on protein stability. The above investigations are in
support of this stability hypothesis but it needs to be tested further. Another
fundamental question to address is what functional groups at the
biomolecule/solid interface are the best for the retention of structure and
activities? Only limited data are currently available on this aspect, however
the use of systematically modified protein and polymer glues can begin to
unravel these details. One major challenge would be to provide biocatalysts
that can function efficiently at high temperatures and in organic media for
applications in organic synthesis, biofuel cells and for the industrial production
of fine chemicals. Although two examples of high temperature biocatalysis are
presented here, there is a high potential for future work. These fundamental
and practical aspects of the enzyme/solid interfaces are likely to be intensely
investigated in future studies.
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Chapter 2.

Biofunctionalization

of

!-Zirconium

Phosphate Nanosheets: Towards Rational Control of Enzyme
Loading, Affinities, Activities and Structure Retention
2.1. Abstract
Controlling the properties of enzymes bound to solid surfaces in a rational
manner is a grand challenge. Here we show that pre-adsorption of cationized
bovine serum albumin (cBSA) to negatively charged !-Zr(IV)phosphate (!ZrP) nanosheets promotes enzyme binding to the modified nanosheets in a
predictable manner, and surprisingly, the enzyme binding to the nanosheets
is linearly proportional to the number of residues present in the enzyme or its
volume, providing a powerful, new predictable tool. The cBSA loaded !-ZrP
(denoted as bZrP) was tested for the binding of pepsin, glucose oxidase
(GOX), tyrosinase, catalase, myoglobin and laccase where the number of
residues increased from the lowest value of ~153 to the highest value of 2024.
Loading depended linearly on the number of residues, rather than enzyme
charge or its isoelectric point. No such correlation was seen for the binding of
these enzymes to !-ZrP nanosheets without the pre-adsorption of cBSA,
under similar conditions of pH and buffer. Enzyme binding to bZrP was
supported by centrifugation studies, powder X-ray diffraction and SEM/EDX.
All bZrP/enzyme complexes examined here retained their secondary
structures to a significant extent, and the extent of structure retention
depended directly on the amount of cBSA pre-adsorbed on !-ZrP, prior to
enzyme loading. Except in the case of tyrosinase, all enzyme/bZrP
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biocatalysts retained their enzymatic activities nearly 90-100%, and
biofunctionalization enhanced enzyme loading on the solid, improved
structure retention and supported high enzymatic activities. This approach of
using a chemically modified protein to serve as a glue, with a predictable
affinity/loading of the enzymes, could be useful to rationally control enzyme
binding for applications in advanced biocatalysis and biomedical applications.
2.2. Introduction
Inorganic nanomaterials provide excellent platforms for enzyme binding
with a high degree of structure and activity retention with improved
stability.60,61,62,63 Here we show that pre-adsorption of cationized bovine serum
albumin (cBSA) onto the anionic nanosheets of !-zirconium phosphate ((!Zr(HPO4)2, denoted as !-ZrP) provided an excellent control over enzyme
binding to the solid. !-ZrP is a highly hydrated, anionic, inert, lamellar material
with a high surface area (100 m2/g)64 and !-ZrP provides a benign
environment for favorable binding of positively charged biomolecules.65
Enzymes intercalated in the galleries of !-ZrP indicated high stabilities and
excellent activity retention (60%-140%)4. The phosphate lattice of !-ZrP
nanosheets provides a uniform, hydrated, charged surfaces for interactions
with positively charged enzymes and proteins.66 However, the strong negative
charge field of !-ZrP severely limits the binding of strongly negatively charged
biomolecules due to the unfavorable electrostatic repulsions.
Several methods were tested to overcome this electrostatic barrier by
tuning the surface charge of the solid via the pre-adsorption of metal ions, for
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example, which served as metal glues for enzyme binding.67 However, the use
of metal ions to promote binding of anionic enzymes to anionic solid surfaces
has an intrinsic risk of inhibiting particular enzymes or deactivating them by
the added metal ion.68,69
In another approach, the COOH residues of negatively charged proteins
were modified with polyamines to reverse their net charge.70 Enzyme
cationization, via the polyamine modification, strongly promoted binding by
several orders of magnitude.8 Chemical modification of enzymes, however,
could be deleterious to the sensitive structures of certain enzymes and it may
not be a practical approach when the enzyme samples are available only in
limited quantities or they do not have sufficient number of accessible sites for
the modification. Alternative, but simpler and universally applicable,
systematic approaches to induce high affinity binding of anionic enzymes to
anionic solids, therefore, will be useful.
In this context, we considered coating !-ZrP with a suitable protein glue
such that the glue binds to both the solid and the enzyme with high affinities,
as an alternative to enzyme chemical modification (Scheme 2.1). Our
approach is two-fold: (1) control the charge of !-ZrP nanosheets by the preadsorption of a sacrificial, cationized protein, and (2) passivate high energy
sites on !-ZrP surface for a high retention of bound enzyme structure and
activities.
A cationic protein glue could offer a robust platform to predict the binding
affinities of a number of acidic proteins to anionic surfaces, as the interactions
between the side chains of the glue and that of the bound enzyme are more
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likely to be governed by protein-protein interactions rather than protein-solid
interactions.
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Scheme 2.1 (A) Schematic representation of biofunctionalization of !-ZrP with
cationized BSA (BSA--TETA(+27)) to prepare bZrP, followed by the binding of
negatively charged proteins. (B) Distribution of anionic (red) and cationic (blue)
residues on the five enzymes and their respective isoelectric points (pI), molecular
weights, areas of cross-sections, and the charge per unit area at pH 7.

54

This approach is tested here by using cationized bovine serum albumin
(cBSA) as the artificial protein-glue and !-ZrP as a model solid (Scheme 2.1).
BSA is an abundant, water-soluble, inexpensive, serum protein with a
molecular weight of 66000 Da, and it is commonly used to prevent cell
adhesion to plastic culture media.71 BSA adsorbs to various non-biological
surfaces and modifies their biodurability and biopersistence.72 For instance,
BSA was used to convert graphene oxide to reduced graphene73, and BSA
adsorption to solids proceeds via electrostatic74,75,76 and/or hydrophobic
interactions.77 The low isoelectric point of BSA (pI, 4.6)
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renders it negatively

charged at pH 7, a desirable pH for biological applications. But, it has a very
weak affinity for the anionic nanosheets of !-ZrP. However, cationization
would enhance the affinity of the modified BSA (cBSA) to anionic solid
surfaces as well as acidic proteins and could serve as potential protein glue.
BSA has been cationized in our laboratories by amidation of its COOH
groups with triethylenetetraamine (TETA) using carbodiimide chemistry
(Scheme 2.1).79 The high positive charge of cBSA favored its binding to
negatively charged DNA80 and in the current studies, we tested the use of
cBSA as a natural adhesive for the favorable binding of strongly anionic
proteins to anionic !-ZrP.
Moreover, BSA has a low structural stability81 and it tends to denature on
binding to many solid surfaces.82,83 This aspect of BSA was also exploited
here to bind and cover the surface of !-ZrP, where cBSA could be spread
across the solid surface covering the phosphate groups of the solid with a
variety of amino acid side chains. The charge of the biofunctionalized cBSA55

ZrP (bZrP) can be controlled by the amount of cBSA loaded on the solid, as
well as by controlling the net charge of cBSA.
Previously, we showed that cBSA could be used to control the binding of
enzymes to the hydrophobic nanosheets of graphene oxide (GO). While the
extent of structure and activity retention of the bound enzymes improved
substantially, enzyme loading on the nanosupport did not respond well.84 One
explanation was that bare GO binds enzymes via hydrophobic interactions,
and blocking these sites with cBSA improved structure/activity retention but
not loading. Here, we tested this explanation using the strongly anionic,
hydrated, ionic surfaces of !-ZrP with negatively charged enzymes to promote
their binding and activity retention with bZrP.
A small set of anionic enzymes (pepsin (pI 185), laccase (pI 3.586), glucose
oxidase (GOX, pI 4.2),87 tyrosinase (pI 4.888), catalase (pI, 5.4) and myoglobin
(pI 6.9)4 with increasing sizes, surface charges (Scheme 2.1), isoelectric
points and different catalytic activities are tested for their binding to bZrP.
Pepsin is a strongly negatively charged proteolytic enzyme, used in peptide
synthesis, but it has little or no affinity for anionic !-ZrP. GOX is an oxidoreductase,89 catalyzes the oxidation of glucose by ambient oxygen, and GOX
is highly promising for biosensor and biofuel cell applications.90 Encapsulation
of GOX in a solid can improve its stability, re-usability and could improve its
practical applications, but GOX binds very poorly to !-ZrP.7,91 Laccase and
tyrosinase are Cu-containing oxidases, which catalyze the oxidation of
phenols and polyphenols while reducing dioxygen to water, and they are
potentially interesting for biofuel cell applications.92 Several metal ions such as
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Fe2+, Co2+, Mn2+, Na+ and K+ inhibit laccase activity93 and such ions could not
be used to enhance the affinity of laccase for !-ZrP. Similarly, Cu2+ and Mn2+
inhibit tyrosinase affinity.94 Therefore, using metal ions to promote the binding
of these anionic enzymes to anionic solids is not an attractive proposition.
Catalase is another anionic enzyme of practical importance, it decomposes
hydrogen peroxide to water and oxygen, under ambient conditions, and plays
a key biological role in neutralizing reactive oxygen species in cells, greying of
hair and protecting the cell from oxidative damage.95
Therefore, the enzymes selected here have potential practical applications
and also provide a spectrum of physical/biological properties. Current
investigations show that cBSA provided a rational control of enzyme loading
on !-ZrP, the extent of structure retention also depended linearly on cBSA
loading, and the enzyme loading scaled linearly with the number of residues
present in the enzyme, rather than its charge. Thus, biofunctionalization of !ZrP with cBSA is an important step in controlling enzyme-solid interface in a
rational, predictable manner.
2.3. Materials and Methods
2.3.1. Materials
Triethylenetetraamine (TETA), Guaiacol, Syringalzine, Laccace, Pepsin A,
GOX, catalase and Bovine Serum Albumin (BSA) were purchased from Sigma
Aldrich (St. Louis, MO). Peroxidase type 1 from horseradish (HRP; specific
activity of 356 U/mg) tyrosinase and were purchased from Calzyme
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laboratories (San Luis Obispo, CA) and Worthington Biomedical Cooperation
(Lakewood, NJ), respectively.
2.3.2. Synthesis of BSA-TETA(+27)
BSA solution (1.5 g) was dissolved in deionized water (DI, 8 ml) and
added to a solution of triethelenetetraamine (TETA, 0.5 M, 5 ml), pH adjusted
to 5 using conc. HCl and the mixture was stirred for 15 min at room
temperature. Then, Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC, 1M, 1
ml) was added and the reaction mixture was stirred for 4 h at room
temperature. The reaction mixture was then dialyzed against 10 mM sodium
phosphate buffer at pH 7.0 using 25,000 Da cutoff membrane for 3 times to
remove any byproducts and excess reagents. Charge reversal of BSA was
confirmed by agarose gel electrophoresis and zeta potential measurements.
2.3.3. Synthesis and exfoliation of α-Zr(IV) Phosphate (α-ZrP)
α-Zr(IV) phosphate was synthesized by following a previously reported
method.96 Mixing of ZrOCl4 solution with phosphoric acid (9 M) followed by
heating at 70 °C for 24 h resulted in white crystalline solid, which was filtered,
washed with acetone, and dried. Powder X-ray diffraction data showed
crystalline material with layer spacings of 7.6 Å, which matched well with
reported values.97 Stacks of the metal phosphate plates were exfoliated with
an aqueous solution of tetrabutylammonium hydroxide until the sample
became translucent, and nanodisks were exposed to desired enzyme
solutions which ultimately resulted in the formation of enzyme/α-Zr(IV)
phosphate complexes.
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2.3.4. Biofunctionalization of !-ZrP
Binding of cBSA to exfoliated !-ZrP nanosheets was followed by
centrifugation studies. Increasing concentrations of BSA-TETA(+27) in 10 mM
sodium phosphate buffer at pH 7 were equilibrated with suspensions of
exfoliated !-ZrP (6 mM) for 1 h at room temperature. Samples were then
mixed well and centrifuged at 12 000 rpm for 6 min (Fisher Scientific
microfuge) to separate bound proteins from free proteins. The concentrations
of free proteins in each supernatant were determined by recording the
absorbance at 280 nm using the molar extinction coefficient as 43 824 M-1 cm1 98

.

A binding isotherm was constructed by calculating the concentrations of

bound proteins from above measurements and data were analyzed using
Scatchard analysis.15
2.3.5. Zeta Potential measurements
Charge of the !-ZrP plates was measured during the binding of BSATETA(+27) by ζ potential titrations (ZetaPLus, Brookhaven, Holtsville, NY).
BSA-TETA(+27) solution (5 µM, 2 µl) were added at a time to a suspension of
!-ZrP (6 mM in DI, pH 6, 1.8 ml). The ζ potential values obtained by the
Smolunchowski fit99 using software supplied by the manufacturer.
bZrP was prepared by adding BSA/TETA(+27) into α-ZrP (6 mM) in 10
mM sodium phosphate buffer at pH 7 when the net zeta potential of the
mixture turns to + 40 mV and this sample was used for all the subsequent
experiments.
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2.3.6. Scanning Electron Microscopy (SEM) imaging studies
α-ZrP (0.5 mM) containing BSA-TETA(+27) (0.2 mg/mL) sample (named
as bZrP) was suspended in 1mL of pH 7.0 Hydro Nanopure distilled water.
500 μL of the suspension was drop-casted onto a Fisherbrand ® 22mm2
microscope silica cover slip (Fisher Scientific). Samples were covered and
allowed to dehydrate for 24h at room temperature in the laboratory fume
hood. Dried specimens were then gently rinsed with Nanopure distilled water
and allowed to further air-dry overnight under previous conditions. Following
light coating under vacuum with gold-palladium using Polaron Sputter Coating
System, SEM observations were performed using JEOL JSM-6335F Field
Emission Scanning Electron Microscope and photomicrographs were taken at
particular magnifications.
2.3.7. Energy Dispersive X-Ray Spectroscopy (EDXS) studies
EDXS was performed on SEM samples using JSM-6335F cold cathode
field emission SEM equipped with Thermo Noran System (JEOL USA Inc,
Peabody, MA). Accelerating voltage and probe current were set to 10 kV and
a dead time of 9 µs, respectively. Using scanning range control, elemental
composition was determined by monitoring Zirconium (Zr), Phosphate (P),
Carbon (C), and Oxygen (O) in the samples within a well-defined area of the
viewing micrograph. Averages of 3 trials of scanning over the desired area
were recorded.
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2.3.8. Enzyme Binding to Bio-functionalized !-ZrP
bZrP samples (10 mM sodium phosphate buffer at pH 7) with a net charge
of +40 mV were used for enzyme binding, and enzyme binding has been
monitored by centrifugation studies. Increasing concentrations of respective
enzymes were equilibrated with bZrP (6 mM) for 1 h and the samples were
then centrifuged at 12 000 rpm for 6 minutes (Fisher Scientific microfuge),
unbound enzyme concentrations in the supernatant were determined by
recording the absorbance using the molar extinction coefficient of
corresponding enzyme at a particular wavelength (Table 2.1). % Loading of
each enzyme has been calculated as w/w percentage with respect to the mas
of each enzyme bound to !-ZrP or bZrP used. Langmuir isotherms were
constructed from these data, according to equation 1.
!
KC
......................................................................................................... (1)
=
!m
1 + KC

In equation 1, & is the amount of protein adsorbed per surface area of the
solid, &m is saturated adsorption, K is the equilibrium constant for the binding
process and C is the concentration of proteins.
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Table 2.1 Extinction coefficients used to calculate the concentrations of unbound
enzyme in the supernatants.
Extinction coefficient (M-1 cm-1)

Enzyme

Wavelength (nm)

Pepsin

280

49 650

Laccase

275

80 000

GOX

450

28 200

Tyrosinase

281

318 720

Catalase

276

912 500

Mb

405

179 000
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2.3.9. Powder X-Ray diffraction studies
bZrP suspensions (300 µl) contained BSA-TETA(+27) loading of 350 g/g
and 6 mM bZrP 300 µl was prepared in 10 mM sodium phosphate buffers at
pH 7. Sample was drop casted on glass slides and closed with a inverted
funnel and allowed it to air dried in the fume hood for two days. Enzyme/bZrP
samples were prepared equilibrating corresponding enzymes with bZrP with
the charge of +40 (30 µM BSA-TETA(+27), 6 mM α-ZrP) in 10 mM sodium
phosphate buffer at pH 7. Samples (300 µl) was drop cased on glass slides
as explained before. The powder XRD was carried out using Rigaku Altima IV
diffractometer (Woodlands, TX) with CuK! radiation (λ = 0.15406 nm) at the
beam voltage and the beam current of 40 kV and 44 mA, respectively. Each
sample was scanned with a continuous scan rate of 1º/min. The interlayer
spacing of bZrP, GOX/bZrP, pepsin/bZrP, laccase/bZrP and tyrosinase/bZrP
were calculated using Braggʼs equation.
2.3.10.

Circular Dichroism (CD) studies

CD spectra of samples of unbound enzymes and enzyme/bZrP complexes
were recorded using Jasco J-710 CD spectrophotometer (Easton, MD) using
0.05 cm path length quartz cuvette in the wavelength range of 260-190 nm.
Samples were prepared by equilibrating protein with bZrP (6 mM) for 1h
followed by centrifugation to remove any unbound proteins. The pellet
obtained was resuspended in 10 mM sodium phosphate buffer at pH 7 and all
protein/bZrP suspensions were diluted to 2 µM of final protein concentration
for CD measurements. CD spectra of protein/bZrP samples (2 µM of protein)
were collected with the scan rate of 10 nm/min with the step resolution of 0.1
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nm/data point. Bandwidth and the sensitivity were set to 1 nm and 50
milidegrees, respectively. Three scans were accumulated for each sample
and the average spectrum was recorded. All CD spectra were corrected for
any residual signal from bZrP, which was very weak due to extensive
denaturation of cBSA on the solid surface, by subtracting bZrP spectra from
those of the samples. To study the effect of BSA-TETA(+27) loading on the
structure retention of enzymes was tested by intercalating 2 µM of GOX in
!-ZrP loaded with increasing concentrations of BSA-TETA(+27) (5-25 µM). All
CD spectra were corrected for any residual signal from bZrP by subtracting
the spectra recorded using the same concentrations of bZrP controls. All
spectra were normalized per micro molar enzyme per 1 cm path length and
the extent of structure retention of bound proteins were compared with those
of the corresponding unbound proteins, measured under same conditions.
2.3.11.

Enzyme activity studies

Activity assays were measured by following published protocols. The
catalytic activity of GOX/bZrP was monitored, for example, by the oxidation of
D-glucose (2 mM) into gluconic acid with ambient oxygen100 and the
production of hydrogen peroxide was measured by its reaction with guaiacol
(5 mM, substrate) catalyzed by HRP (1 µM). Guaiacol oxidation resulted in a
colored product whose formation was monitored by following its absorption at
470 nm as a function of time. Kinetics data were plotted using Kaliedagraph
(version 4.1.3) and the initial data were used to calculate the initial rates and
specific activities. The activity of GOX bound to bZrP was then compared with
that of unbound GOX under the same experimental conditions.
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Pepsin assay101 was performed based on the rate of hydrolysis of
hemoglobin (Hb) by pepsin. Pepsin/bZrP (0.5 mg/ml of enzyme) was
dissolved in 0.01 N HCl and chilled prior to the assay. Hb, the substrate (2.5
g) was dissolved in 100 ml of DI water and 80 mL of this solution was diluted
with 20 mL of 0.3 N HCl. Hb solution (2.5 mL each) was then added to nine
numbered test tubes and incubated at 37 ºC in a water bath. First 1-3 test
tubes were kept as blank and Trichloroacetic acid (5% w/v, TCA) solution (5
mL) was added to the each tube followed by pepsin (2 µM). Samples were
removed from the bath after 5 min, filtered and the absorbance was measured
at 280 nm of clear filtrates. 0.5 mL of pepsin/bZrP (2 µM) was then added to
the each test sample (4-6) at timed intervals and equilibrated at 37 ºC for
exactly 10 min followed by the addition of TCA (5 mL) to quench the reaction.
Samples were removed from the bath after 5 min and the absorbance of the
filtered, clear samples were measured at 280 nm. Similarly, samples (7-9)
were treated with unbound pepsin (2 µM) and the absorbance of the blank at
280 nm was subtracted from each test sample to get the hydrolysis of Hb by
pepsin.
Tyrosinase activity102 was done with L-tyrosine as the substrate.
Tyrosinase oxidizes the L-tyrosine to dihydroxyphenylalanine, which is then
further oxidized to the corresponding o-quinone. Absorbance of the sample at
280 nm was measured, as a function of reaction time. In brief, tyrosinase (2
µM) in 0.5 M potassium phosphate buffer at pH 6.5 was added to L-tyrosinase
(1 mM). Absorbance at 280 nm was measured for 10 minutes while stirring.
Same procedure was followed with tyrosinase/bZrP (2 µM) and the initial
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absorbances were used to calculate the initial rates and the corresponding
specific activities.
Laccase activity103 was monitored using Syringaldazine as the substrate.
The rate of oxidation of Syringaldazine by laccase to oxidized Syringaldazine,
which has an absorbance maximum at 530 nm was monitored. Syringaldazine
(1.167 mg) was dissolved in methanol (15 mL) and 32 µM of this solution was
added to laccase (1 µM) in 0.1 M sodium phosphate buffer at pH 6.5. Increase
in absorbance at 530 nm was measured at room temperature and the initial
rates were compared with that of the laccase/bZrP.
2.3.12.

Differential scanning calorimetry (DSC)

Thermal denaturation of enzyme/bZrP complexes was performed using
Nano II differential scanning calorimeter (DSC) 6100 (Calorimetry Sciences
Corporation CSC, Utah). An aqueous suspension of enzyme/bZrP samples (in
10 mM Na2HPO4 buffer pH 7.2) was scanned using 10 mM Na2HPO4 buffer
pH 7.2 as the reference sample. The amount of heat required to increase the
temperature of a sample with respect to the reference was monitored in a
series of heating and cooling scans equilibrated at 20 ºC for 10 minutes and
scanned from 20 to 100 ºC at a scan rate of 2º C/min. The excess molar heat
capacities of the samples were calculated using molar masses of
corresponding proteins. When the denaturation is irreversible, model
independent parameters, peak transition temperature (Tm), the temperature
where the denaturation begins and ΔHdenaturation (integral CpdT) were extracted
from the DSC data. Thermograms of the corresponding unbound enzymes
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and bZrP (!-ZrP/BSA-TETA(+27)) also recorded under similar conditions, and
the enzyme/bZrP complexes were compared with those of the corresponding
unbound enzymes.
2.4. Results
The !-ZrP nano sheets are attractive nanomaterial for enzyme
intercalation as this improves thermal stabilities and in some cases, activities
of biocatalysts.4 However, !-ZrP has very poor affinities for strongly
negatively charged enzymes due to the unfavorable electrostatic interactions
between the solid and the enzyme. In the current studies, highly cationized
BSA-TETA(+27) was pre-adsorbed on the !-ZrP nanosheets, so that the
surface has a net positive charge and provided a variety of amino acid side
chains for interactions with acidic enzymes. The cationized-BSA loaded !-ZrP
(denoted as bZrP) showed enhanced binding of acidic proteins when
compared to !-ZrP and bound enzyme properties are either improved or
retained to a significant extent. These details are presented below.
2.4.1. Cationization of BSA and binding to !-ZrP
The COOH groups of BSA were modified with triethylenetetraamine
(TETA) via carbodiimide chemistry (Figure 2.1A).104 The BSA-TETA sample
was purified by dialysis to remove unreacted EDC, TETA and the
transformation of negatively charged BSA into a cationic protein was
monitored by agarose gel electrophoresis and ζ potential measurements.
The agarose gel (Figure 2.1B) of the pristine BSA (lane 1) and cBSA
purified by dialysis (lane 2) indicated that the negatively charged BSA (pH 7)
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moved to the positive electrode, whereas the modified BSA moved towards
the negative electrode. These data confirm the conversion of the anionic BSA
to the corresponding cationized protein. Each TETA side chain can provide
multiple positive charges, depending on the pH conditions. The four basic
nitrogens present in TETA, for example, can be protonated at particular pH
values (pKa1=3.32, pKa2=6.67, pKa3=9.2, pKa4=9.92) and only three of these
will be available for protonation, after conjugation with the COOH group of
BSA.105 Also note that the pKa values will be shifted up due to the amidation
of one of the TETA nitrogens and hence, each TETA modification could
provide only 2-3 positive charges depending on the pH. The electrophoretic
mobility was used to calculate the net charge on the BSA-TETA conjugate to
be +27 and that of BSA corresponded to -18, which is in agreement with
literature values.2 The estimated charge of BSA-TETA has been confirmed by
ζ potential measurements (Figure 2.1C) and the sample denoted as BSATETA(+27).
The secondary structure of BSA-TETA(+27) was examined by deep UV
circular dichroism (CD), spectroscopy and the CD spectrum of the cationized
sample matched well with that of the untreated sample (Figure 2.1D, red and
blue curves, respectively).

68

A

1 2

Figure 2.1 (A) Cationization of BSA by amidation of its carboxylic groups with
triethylenetetraamine (TETA) using carbodiimide chemistry. (B) Agarose gel
electrophoresis image of BSA (lane 1) and cationized BSA (BSA-TETA(+27) (lane 2).
The gel ran at pH 7.0 in 40 mM Tris acetate buffer. (C) The zeta potential of
cationized BSA (BSA-TETA(+27), 30 µM, 2 ml DI) (D) CD spectra of BSA(blue, 2
µM), BSA-TETA(+27) (red dashed, 2 µM) and BSA-TETA(+27) bound to α-ZrP (6
mM (bZrP), all samples for CD are suspended in 10 mM sodium phosphate buffer,
pH 7
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The BSA-TETA(+27) was then adsorbed on to exfoliated !-ZrP nano
sheets and the extent of binding compared with that of BSA (Figure 2.2A) (red
and blue dots, respectively). The binding data were fitted to equation 1, and
the association constant (kb) as well as saturation binding (Bmax) obtained.
BSA-TETA(+27) binding affinity of 7.8 × 104 M-1 for !-ZrP when compared to
1.2 × 105 M-1 for BSA and Bmax increased from 0.8 ± 0.2 to 11.2 ± 1.0 g/g, a
15-fold improvement for the cationized protein over that of BSA.
The UV CD spectra of bZrP (Figure 2.1D, black line) showed that
nearly 90% of cBSA structure was lost on binding to !-ZrP and hence, protein
is unraveled on the nano sheets exposing the amino acid side chains of cBSA
for interactions with the solvent or other substances that can be absorbed on
bZrP. Binding of cBSA to !-ZrP was also confirmed in ζ potential
measurements. Ionized phosphates on the !-ZrP renders it negatively
charged (1 charge/25 Å2) at neutral pH, and the binding of BSA-TETA(+27) is
expected to diminish this negative charge or even reverse the net charge.
Titration of a suspension of exfoliated !-ZrP nanosheets with aliquots of BSATETA(+27) (0-50 μM) indicated progressive increase in charge from -40 to
+38 mV (Figure 2.2B). We suspected that these surfaces would be more
benign for protein binding and facilitate the binding of anionic proteins to the
cationic bZrP. The BSA-TETA(+27) adsorbed !-ZrP (bZrP) was further
characterized prior to the binding of negatively charged proteins.
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Figure 2.2 (A) Binding isotherm of BSA-TETA(+27) (Blue dots) and BSA (Red dots)
binding to !-ZrP. The Langmuir isotherm was used to analyze data and best fit is
shown. (B) ζ potential titration of !-ZrP (6 mM) with increasing concentrations of
BSA-TETA(+27).
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2.4.2. Morphology and elemental analysis of bZrP
The composition of bZrP was examined by SEM and EDX to gain insight
into the location of the protein with respect to the inorganic matrix. SEM
micrographs of bZrP at 16,000x magnification (Figure 2.3A) show distinct
flakes of Zirconium Phosphate nanoplates as opposed to the condensed
stacks observed for α-ZrP earlier.5 Further analysis with EDX at 45,000x
magnification was used to determine the elemental composition profiles, after
focusing on a single exfoliated nanoplate. Using the line-count method, which
scans across a field of a sample (Figure 2.3B, arrow), distinct peaks for
oxygen and carbon were found at the same region of the plate (Figure 2.3C).
These spikes correlated with the peaks of zirconium and phosphate profiles,
which confirmed the presence of the carbon-based protein bound to the !-ZrP
nanoplates.
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Figure 2.3 (A) SEM, (B) EDX line image of a single flake of bZrP and (C) Elemental
microanalysis abundances as a function of distance along the line shown in Figure
2B
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2.4.3. Enzyme binding to bZrP: Affinities and loadings
The above hypothesis of the binding of acidic proteins to catinic bZrP was
tested with a small group of anionic proteins with increasing sizes, isoelectric
points, surface charge distributions and catalytic activities. Pepsin is strongly
negatively charged (pI =1) and bound to bZrP even at very low enzyme
concentrations (Figure 2.4A, red dots) while it had essentially no binding to !ZrP (Figure 2.4A, blue dots). A maximum loading 1.68 g of pepsin per 1g of
bZrP was noted, while there was no binding of pepsin to !-ZrP, under the
same conditions. These binding data were analyzed with the Langmuir model
and the best fit indicated a binding constant of 2.5 × 105 M-1.
The maximum loading of pepsin was used to calculate the fraction of the
available area occupied by using its area of cross section of 23 Å2 106 and the
surface area of !-ZrP as ~100 m2/g 5. The coverage turned out to be about
5.8 % of the total available area, and large unoccupied spaces are left out,
which could be useful for ingress or egress of reagents/substrates/products.
In a similar fashion, we determined the binding of the remaining enzymes
and find that GOX (Figure 2.4C, red line) and catalase (Figure 2.4E, red line)
bind to bZrP with the affinity constant of 4.4 × 105 M-1 and 9.0 × 105 M-1,
respectively. Analysis of GOX binding to bZrP by Langmuir isotherm indicated
B

max

of 6.5 g/g, which is much higher than the loading observed for !-ZrP

(0.8 g/g). However, catalase and Mb did not discriminate between bZrP and
!-ZrP to a significant extent but the initial data points indicated significant
differences.
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Figure 2.4 Binding isotherms of (A) pepsin, (B) laccase, (C) GOX, (D) tyrosinase, (E)
catalase and (F) Mb with bZrP and !-ZrP (6 mM, error bars are too small to be
visible in some cases). Langmuir model was used to analyze data and best fits are
shown in each case.
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Laccase and tyrosinase also showed higher affinities for bZrP when
compared to !-ZrP (Figure 2.4B,D). In addition to the Bmax obtained from the
best fit to the Langmuir isotherm, we also calculated the highest loadings
observed experimentally at the highest initial protein concentration used for
above proteins with bZrP are compared with those of α-ZrP (Figure 2.5).
Pepsin, laccase, GOX, and tyrosinase showed maximal loadings of 150, 190,
640, 380 and 130 (w/w%) on bZrP, which are higher than the corresponding
loadings on α-ZrP except in the case of Mb (0, 170, 85, and 110 and 140
w/w%, respectively)
Binding of the anionic proteins to the bZrP could release cBSA into the
solution, and this possibility was tested explicitly with GOX. There was no
release of cBSA when solutions of GOX (2-20 µM) were equilibrated with
bZrP (6 mM with the charge of +38 in 10 mM Na2HPO4) as monitored by
absorbance of the supernatant at 280 nm, after removing the bound protein
from the equilibrated mixture. Therefore, under our binding conditions with
GOX, there was no release of cBSA.
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Figure 2.5 Maximal loadings (% w/w) of pepsin, laccase, GOX, tyrosinase and Mb to
bZrP (6 mM, red bars) and !-ZrP (6 mM, blue bars). Total concentration used in
each case is pepsin- 100 µM, laccase- 64 µM, GOX-100 µM, tyrosinase-64 µM, Mb150 µM.
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2.4.4. Intercalation of proteins in bZrP
To test the binding of enzymes between the bZrP nanoplates via
intercalation, we examined the powder XRD patterns of enzyme/bZrP
complexes. If the large enzyme molecules intercalate in the galleries of the
bZrP, the gallery spacing should increase by the diameter of the intercalating
enzyme. On the other hand, if the binding takes place at the edges of the
bZrP, the gallery spacing will be the same as that of bZrP. The interlayer
spacings of bZrP (80 Å, Figure 2.6A, red line) are greater than that of !-ZrP
(Figure 2.6 inset, 7.6 Å) or that of exfoliated TBA/!-ZrP (Figure 2.6, black line,
17 Å).107 The new peak at the 80 Å is comparable with two of the three
dimensions of BSA, 84 Å × 84 Å × 35 Å.108 Upon enzyme binding to bZrP, the
spacings increased further. Binding of pepsin and tyrosinase increased these
d-spacings to 140 (Figure 2.6, blue line) and 117 Å (Figure 2.6, green line),
respectively. These increases in d-spacings are consistent with the
intercalation of pepsin and tyrosinase, and data on other systems are not
collected.
2.4.5. Bound enzyme structure
The extent of retention of the native-like structures of bound enzymes was
tested by CD spectroscopy.109 Using GOX as a model system, we tested the
influence of cBSA loading on the extent of structure retention of bound GOX,
at constant concentration of GOX. Thus, several bZrP samples with
increasing loadings of of BSA-TETA(+27) (0-35 µM) on !-ZrP (6 mM) with
GOX (10 µM) was equilibrated and CD spectra recorded in the deep UV
region.
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Figure 2.6 (A) Powder XRD patterns of !-ZrP (inset), exfoliated !-ZrP (TBA/!-ZrP)
(black line), bZrP (red line), pepsin/bZrP (blue line) and tyrosinase/bZrP (green line).
Corresponding d-spacings are shown in parentheses on each curve. (B) The far UV
CD spectra of GOX (dark blue line) and GOX/bZrP (light blue line). (C) Structure
retention protein/bZrP samples measured by comparing ellipticities at 222 nm with
that of unbound protein. (D) GOX structure retention (%) vs cBSA loading for
GOX/bZrP samples.
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The secondary structure of GOX gradually improved as a function of
increasing BSA-TETA(+27) loading. As estimated from the 222 nm band
intensities, the GOX structure improved from 43 to 125% as the BSATETA(+27) loading increased from 0 to ~95 (w/w %) of cBSA to !-ZrP (Figure
2.7D). Under these conditions, the CD spectrum of GOX/bZrP showed its
characteristic minima at 210 and 222 nm (Figure 2.7B, light blue line), which
more or less, overlapped with that of GOX (Figure 2.7B, dark blue line). In
control experiments, cBSA bound to ZrP had no detectable CD, under similar
conditions. Hence, bZrP samples with 90 % w/w loading of BSA-TETA(+27) to
!-ZrP were used for all subsequent studies. For example, the extents of
structure retention of pepsin, laccase, tyrosinase bound to bZrP were nearly
98-100% (Figure 2.7C).
2.4.6. Activities
The effect of biofunctionalization of !-ZrP on the catalytic activities of the
bound enzymes was compared with those of the enzymes bound to !-ZrP.
Product formations for each of these catalytic reactions were monitored by
appropriate methods and the specific rates calculated and compared. For
example, the kinetic traces for the GOX, GOX/!-ZrP and GOX/bZrP are
compared in Figure 2.7A, which are nearly the same. The initial rates of these
reactions as obtained from the slope of the tangent to the curve zero reaction
time are then used to calculate the corresponding specific activities (Figure
2.7B). All the enzyme/bZrP complexes are nearly comparable to the
corresponding free enzymes and enzyme/!-ZrP samples with the exception of
tyrosinase. Binding of tyrosinase to !-ZrP essentially deactivated it while bZrP
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restored the activity to a significant extent (>40%). Thus, biofunctionalization
of ZrP had a significant effect on tyrosinase activity.
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A

B

Figure 2.7 (A) Activities of GOX/bZrP (red line), GOX/!-ZrP (blue line) and GOX
(black line) measured by kinetic traces monitoring the absorbance at 470 nm. (B)
The retention of the enzymatic activities of enzyme/bZrP and enzyme/!-ZrP
complexes in comparison to those of the respective free enzymes.
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2.4.7. Thermal stabilities of enzyme/bZrP complexes
Another important attribute for biocatalysts is their thermal stability and
passivation of high-energy sites on the solid with cBSA is expected to
enhance the bound enzyme stabilities. DSC provides quantitative measured
of the denaturation enthalpy (ΔH) and the denaturation temperature (Tm), in a
model independent manner (Table 2.2). The DSC profiles of GOX and
GOX/bZrP are compared in Figure 2.8.
Thermogram of GOX/bZrP (Figure 2.8A, blue line, ~300 g/g) shows that
the enzyme begins to denature at 60 ºC with a peak maximum of 72 ºC and
continues to denature upto 80 ºC with relatively sharp thermal transition. On
the other hand, GOX started to denature at 45 ºC and continued upto 66 ºC
(Figure 2.8A, red line). The contribution of bZrP to these profiles is negligible
(Figure 2.8A, purple line) as cBSA loaded on the solid is completely denatured
(see CD studies). The areas under the curves (∆H) for GOX and GOX/bZrP
gave the corresponding denaturation enthalpies to be 319 and 250 kcal/mol,
respectively.
DSC profiles of GOX/bZrP were examined as a function of GOX loading
(~90 to ~300 w/w %), and the Tm gradually increased from 60 to 72 ºC (Figure
2.8A),

while

thermal

transitions

became

progressively

sharper

with

concomitant increase in both ∆H. Thus, GOX retained better structure and
higher thermal stabilities, as its loading is increased.
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Figure 2.8 (A) DSC thermograms of the GO/bZrP as a function of GO loading. (B)(D) DSC thermograms of pepsin, tyrosinase and laccase (red lines, each 2 mg/ml)
and their respective bZrP complexes (blue lines). Loading at each level is
represented as w/w % of each protein on bZrP (6 mM, !-ZrP and 30 µM, BSATETA(+27)) is shown in parenthesis. All samples were prepared in 10 mM sodium
phosphate buffer at pH 7.
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In contrast to GOX, intercalation of pepsin in bZrP (80 w/w %), however,
lead to lower thermal stability. Both Tm and ∆H decreased (58 to 48 ºC and 92
to 60 kcal/mol, respectively, (Figure 2.8B). The DSC profiles of laccase and
tyrosinase (pH 7.0, 1 mg/ml) had multiple transitions, which were previously
assigned to multiple domains.110 Tyrosinase/bZrP (50 w/w %) indicated small
increase in Tm from 72 to 76 ºC (Figure 2.8B). Laccase had a major
denaturation transition at 85 ºC with ∆H of ~20 kcal/mol and laccase/bZrP
(125 w/w%) indicated no change in Tm but ∆H increased 9-fold (Figure 2.8D).
On the whole, GOX, tyrosinase and laccase indicated improved thermal
stabilities while pepsin was marginally destabilized by bZrP.
Table 2.2 Thermodynamic parameters for enzymes and their corresponding
enzyme/bZrP complexes. All samples were tested in 10 mM sodium phosphate
buffer at pH 7
Sample

ΔHd (k cal/mol)

Tm (ºC)

Free

Bound

Free

bZrP

-

-

Pepsin

92 ± 2

60 ± 14

58

48

GOX

319 ± 32

250 ± 14

59.6 ± 0.5

72

Tyrosinase

121 ± 12

112 ± 5

50, 72

50, 76

Laccase

21 ± 0.2

181 ± 5

85

75, 85

-

Bound
-

Overall, coating of !-ZrP nanosheets by simple, one step pre-adsorption of
cBSA expanded the utility of !-ZrP for enhanced protein loading while
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maintaining their native –like structures and activities with enhanced thermal
stabilities in specific cases.
2.5. Discussion
Previous investigations positioned !-ZrP as an effective solid platform for
protein and enzyme binding with improved thermal stabilities and even
enhanced activities when compared to the corresponding unbound enzymes.
1,24

One advantage of this solid was its strong negative charge field which

binds a number of positively charged proteins as well as marginally negatively
charged proteins. However, this strength is also its limitation. Strongly
negatively charged enzymes such as the ones examined here, except laccase
and catalase, bind poorly to !-ZrP due to unfavorable electrostatic
interactions. Pre-adsorption of !-ZrP with a sacrificial, strongly cationized BSA
overcomes this electrostatic barrier and also provides a variety of amino acid
side chains for favorable interactions with the enzyme.
BSA is often used to reduce non-specific protein binding to surfaces, and
hence highly cationized BSA indicated improved affinity for !-ZrP (ζ -40 mV)
and enhanced the binding of pepsin, GOX, tyrosinase and Mb, while laccase
and catalase had comparable affinities with both forms of the solid. This
improvement in the binding of anionic proteins to bZrP is a result of the
charge reversal where cBSA acted as an excellent anchor where it bound to
both the !-ZrP surface as well as the anionic enzymes. This approach
appears to be universal for binding anionic proteins, as all the samples
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examined here with a wide range of pI values and molecular weights and
shapes indicated binding to bZrP.
BSA-TETA(+27) indicated a moderate binding constant of 7.8 × 104 M-1 for
α-ZrP, but indicated very high loading. Powder XRD data indicated an
average thickness of the BSA-TETA(+27) layer on α-ZrP at 350% (w/w) to be
80 Å (Figure 2.6, red line), and this layer is thicker than the average diameter
of BSA (62 Å)111. At the highest loading cBSA of 500% (w/w) observed (Figure
2.2A) there could be certainly multiple layers of BSA. The binding of BSATETA(+27) to α-ZrP was also confirmed by ζ potential titrations (Figure 2.2B).
As the binding progressed, the net charge of α-ZrP changed from -40 to + 38
mV. After the charge on the α-ZrP surface is fully neutralized, binding
continued. This process resulted in an accumulation of excess positive charge
on the bZrP nanosheets. A similar phenomenon, the overcharging, was
observed during polyion binding to DNA, which may consider as a onedimensional analogue of α-ZrP and the layer-by-layer assembly of polymer
polyelectrolytes as well.112 The bZrP served as a cationic analog for the
binding of anionic enzymes where the loading capacity has been considerably
improved.
The loadings of pepsin, laccase, GOX, and tyrosinase and Mb showed
improved maximal loadings of 150 to 0, 190 to 170, 640 to 85, 380 to 110,
and 140 to 130 % w/w, respectively (Figure 2.5). In contrast to the preferential
binding of pepsin, GOX and tyrosinase to bZrP, laccase and catalase showed
comparable loadings to both solids. One possible reason might be that the
positively charged patches on these enzymes (Scheme 2.1) facilitate binding
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to the anionic !-ZrP while the negatively charged patches favor binding to
bZrP. However, their isotherms display linear increase in loading with the
initial enzyme concentration without saturation binding even at very high
protein concentrations.
The above enzyme loadings, in general, far exceeded those known for
other solid supports. For instance, pepsin binding to alumina nanoparticles
(20 nm) gave a maximum loading of 0.13 g/1g of pepsin to alumina,113 which
is far less than 150%w/w loading observed here. Among various carbonbased materials used for GOX loading, mesocellular carbon form showed only
40% (w/w GOX to carbon) maximum loading114 when compared 640% w/w
observed in the current studies with bZrP. A recent study also shows that the
covalent immobilization of tyrosinase on carbon nanopowder and singlewalled carbon nanotubes with maximum loadings of 210% w/w,115 which is
also below the 380% w/w loading, observed with bZrP.
Powder XRD studies indicated that the binding of proteins to bZrP takes
place via intercalation mode, which we have previously shown for protein
binding to α-ZrP. Observed d spacing for protein/!-ZrP complexes was
attributed to the intercalation of a monolayer of the protein and several layers
of water molecules.32 The d-spacing observed for pepsin/bZrP (140 Å) in the
current studies is much higher than the d-spacing of bZrP (80 Å) plus the
reported dimensions of the pepsin (70 × 40 × 30 Å).

54

Also note that the

pepsin loading saturated around 5.8% w/w and therefore, these observations
suggests that the on coming protein resides on the pre-adsorb underlying
cBSA layer. The d-spacing noted for tyrosinase/bZrP (117 Å) also supports
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the idea that these proteins bind on top of cBSA layer, and in the case of
GOX/bZrP the spacings were too large to be measured here.
The UV CD data showed that all four enzyme/bZrP samples examined
here retained most of their native-like structures (Figure 2.6). Structure
distortion is often observed on binding of most proteins to most of the solid
surfaces. For example, GOX underwent extensive conformational changes
with decreasing !-helicity and excessive unfolding upon binding to graphene
oxide.116 In contrast, some conformational changes of protein were noticed
when hemoglobin or myoglobin bind to bare !-ZrP and co-intercalation of
these proteins with DNA improved their structure retention considerably.6
Hence, the underlying BSA-TETA(+27) layer in bZrP may provide a benign
environment for the bound proteins by blocking high energy sites on solid
surfaces, which may contribute to the protein structure loss and this
conclusion was also supported by the extensive retention of bound enzyme
activities.
The specific activity of pepsin bound to bZrP is comparable to that of
unbound pepsin (3.0 × 10-2 µM-1 vs 2.8 × 10-2 µM-1,). Catalytic activity of
pepsin/bZrP requires that the substrate (Hb) bind to the active site cleft in the
bilobal structure of pepsin. Hence, the gallery spacing of 140 Å noted in the
XRD studies for this biocatalyst is large enough for the ingress-egress of the
large substrate. Among various solid supports used for immobilizing pepsin, a
recent study shows only 22 % retention of pepsin activity on SBA-15
mesoporous silica while using the same substrate as here, Hb.117 Hence, in
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comparison to other solids, pepsin retained higher activity on bZrP
nanolayers.
Complete retention of activity was also observed for laccase/bZrP complex
(2.2 × 10-2 µM-1 vs 2.1 × 10-2 µM-1), which is much higher when compared to
reported activity retention of 26-64% observed for laccase adsorbed on
inorganic minerals.118 The specific activities of GOX, GOX/!-ZrP and
GOX/bZrP (3 × 10-2, 2.8 × 10-2 and 2.5 × 10-2 µM-1, respectively) are
essentially the same as the unbound enzyme, whereas only 25% of specific
activity was retained when immobilized on to multiwall carbon nanotubes
which improved to 65% upon covalent immobilization using a PEG linker.119
While complete activity loss was noted for tyrosinase/!-ZrP, tyrosinase/bZrP
retained 50% of its activity and tyrosinase entrapped on molecular sieves,
silica gel, alumina-G, sepharose beads showed only <40% retention of
activity.120 However, it is known that tyrosine oxidation by this enzyme exhibits
an initial lag phase, which is known to be shortened or even eliminated by the
addition of catalytic amounts of o-diphenol or transition metal ions.121 This
initial lag phase is absent for tyrosinase/bZrP, which is a considerable
additional advantage.
The benign nature of the bZrP interactions with the bound enzymes was
further confirmed by the DSC data (Table 2.2). Constraining enzymes within
the two-dimensional space of !-ZrP improved thermal stabilities of the
intercalated proteins.122 However, these thermograms showed extensive
broadening, which was attributed to the heterogeneity in the bound enzyme
population, and hence, the situation is expected to improve by blocking the
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high energy sites with cBSA, providing a more benign environment rather than
the phosphate lattice of the bare !-ZrP. To test this possibility, we performed
DSC studies on protein/bZrP complexes. The Tm of GOX/bZrP improved from
60 ºC for the unbound GOX to 72 ºC for GOX/bZrP at high loadings of ~300%
(w/w). While lower Tm values were noted at lower loadings (Figure 2.8A), the
loading clearly played an important role and transitions were sharper at all
loadings. Thus, favorable interactions with the surrounding protein-o-philic
environment of bZrP could also be important. Pepsin/bZrP indicated a 10-ºC
drop in its Tm when compared to that of the unbound enzyme, and the ∆H
decreased from 92 ± 2 to 60 ± 14 kcal/mol (Figure 2.8B). Multiple domains
observed in the thermograms of tyrosinase (Figure 2.8C) and laccase (Figure
2.8D) were preserved in their corresponding bZrP complexes, and this is an
interesting observation. However, tyrosinase/bZrP indicated preponderance of
the higher temperature transition. These observations are in contrast to the
extensive broad profiles reported for of protein/!-ZrP samples, in our previous
studies.5
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Figure 2.9 Plot of enzyme % loading (w/w) on bZrP vs (A) net charge at pH 7 (B)
number of residues (C) volume of the enzyme. In each case 6 mM bZrP or !-ZrP
was used, and all loadings were calculated at 8 µM total protein concentration.
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The binding interaction is more complex than expected from a simple
electrostatic model, where the binding or the loading should scale with
increase in the negative charge of the enzyme, as bZrP is strongly positively
charged. The binding affinities or the loadings with bZrP had no correlations
with the pI or the net charge of the protein or the charge of the complex
formed (Figure 2.9A). However, the loading on bZrP showed a strong linear
correlation with the number of residues present on the enzyme (Figure 2.9B,
red dots, R=0.97) where the number of residues increased from ~153 to 2024.
Comparison of the corresponding loadings to !-ZrP (blue dots) indicated
considerable scatter. Linear fit to the bZrP data (black line) indicated a slope
of 0.06% loading per residue and non-zero intercept, and loading also
increased linearly with number of residues at higher protein loadings. These
data suggest that the loading increases linearly with the number of residues or
that the binding interaction with bZrP is intrinsic to the interactions with the
amino acids of the incoming enzyme, rather than other properties. This
conclusion and the good ness of the fit with R=0.97 is significant, as this
provides a powerful new tool to predict loadings of a given enzyme for bZrP
simply based on the number of residues. To the best of our knowledge this is
the first report of number of residue dependence protein loading on a given
nano-bio interface.
To test if the above correlation is due to gradual increase in the size of the
enzyme with increasing number of residues, we investigated the correlation
between the loading and the size of the enzyme (Figure 2.9). As the size
increases the number of possible contacts that can be made between the
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enzyme and the solid surface also increases with a strong linear correlation
(R=0.96) having a slope of 0.8 % w/w loading per unit volume of the enzyme.
Hence the volume of the enzyme, which also known to increase with
increasing the number of residues123 can be used as a measure of its loading
capacity on the bZrP surface but note the differences in the intercepts. One
difference between the two plots is the X-intercept. While this is nearly zero
for the plot of number of residues vs loading, it is considerably negative for the
volume vs loading plot. Thus, a minimum volume may be essential for the
binding to take hold on the bZrP surface but this possibility needs to be tested
in future studies.
In contrast to pristine !-ZrP, which has shown low affinity for negatively
charged biomolecules, cationic bZrP improved the binding of negatively
charged enzymes with exceptional loading capacity while retaining nearly
100% structure and activity retention. Thus, the current method of coating the
nanosheets with cBSA to alter its net charge as well as the surface
characteristics provides a good foundation to improve the functionalities of
nanomaterials as benign supports for enzyme binding in a predictable
manner.
2.6. Conclusions
Current results illustrate the biofunctionalization of α-ZrP with a protein
glue and its effect on enzyme/protein binding on the modified !-ZrP (bZrP)
surface compared to that of pristine !-ZrP surface. Conversion of
homogenous inorganic nanosurface inherently decorated with phosphate
groups into a pool of amino acid side chains enhanced the effectiveness of
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the surface for enzyme binding. As a result, many acidic enzymes showed
greater affinities toward bZrP while maintaining native-like structures and
activities for the bound enzymes.
On the other hand, enzyme loading on bZrP or the pristine solid did not
show direct correlation with the net charge of the enzyme, which suggests
that the electrostatic interactions are not dominant factors for the underlying
binding interactions. The enzyme loadings on bZrP revealed a strong
dependence on the number of residues and their sizes, but these two
parameters are inter-related. Nevertheless, the conclusion is that the current
approach provides a predictable method for enzyme loading, for the first time,
and binding is dominated by intrinsic interactions between the enzyme and
the protein-glue coated solid surface. Further experiments are needed to test
if this strategy will work with other solid surfaces and if other protein-glues can
be used in place of cBSA. Fundamental insights gained from the current
studies

are

useful

to

rationalize

protein-solid

interactions,

and

biofunctioanlization as developed here provides an added value to the natural
surface. These insights are important to regulate the bio-nano interfaces to
construct bio-functional materials while ensuring their structure and activity
retention.
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Chapter 3.

Synthesis and Characterization of Novel

Bionanoparticles
3.1. Abstract
This chapter describes the synthesis of a wide variety of nanoparticles by
a novel bottom-up approach. Focus is on a new, simple, and versatile method
developed in our laboratory where a simple apparatus has been used to
prepare nanoparticles from a number of different materials. For example,
nanoparticles of met-hemoglobin and glucose oxidase are readily prepared by
contacting a fine spray of aqueous solutions of the proteins with an organic
solvent such as methanol or acetonitrile. The protein nanoparticles suspended
in organic solvents, surprisingly, retained their secondary structure and
biological activities to a significant extent. This approach has been used to
successfully prepare nanoparticles of transition metal complexes, organic
molecules, nucleic acids, inorganic polymers, and synthetic organic polymers.
Particle size depended on reagent concentrations, pH and the solvent used,
and particle sizes have been controlled from 20 to 200 nm by adjusting these
parameters. Nanoparticles made from met-hemoglobin, glucose oxidase, and
calf thymus DNA indicated retention of their native-like structures, as
evidenced from their respective circular dichroism spectra. Enzyme
nanoparticles retained their catalytic activities to a significant extent. For
example, peroxidase-like activity of met-hemoglobin nanoparticles suspended
in methanol was 0.3 µM-1 s-1, which is comparable to the activity of methemoglobin in aqueous buffer (1.0 µM-1 s-1), even though the former has been
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measured in methanol. Thus, the nanobiocatalysts retained substantial
activity in organic solvents. Nanoparticles of anthracene indicated extensive
excitonic coupling due to inter-chromophore interactions. The current method
of nanoparticle synthesis is rapid, simple, versatile, reproducible, universal
and resulted in the formation of nanoparticles from a variety of materials,
many of them for the very first time.
3.2. Introduction
Over the past decade or more, the synthesis of nanoparticles has been
intensively studied not only due to their fascinating properties, but also for
their potential for a wide variety of applications.124 Their high promise is due to
several of unique properties such as high surface area, and their
characteristics are quite distinct from those of the corresponding bulk
materials. Nanoparticles have a very high potential for a wide variety of
applications, which include but not limited to sensing,125 catalysis,126,127,128 drug
delivery,129 biomedical applications,130,131 energy technologies, solar light
harvesting132 and environmental remediation.
One major goal in this field has been to produce nanoparticles with
uniform size, high stability and interesting properties. During the past decade,
numerous reports for the synthesis and characterization of nanoparticles of
inorganic salts, organic molecules, biological polymers, synthetic polymers
and metal complexes have been reported. The synthetic strategies are
typically grouped into two categories (Scheme 3.1): “top-down” and “bottomup”. The first utilizes physical methods to divide bulk solid into smaller
portions by a variety of divisional methods.133 This approach may involve
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milling, grinding, and volatilization of a solid followed by condensation of the
vapor. Although this strategy can produce large quantities of nanoparticles,
controlling the size and the uniformity of particle size are difficult. On the other
hand, the “bottom-up”, method involves condensation of atoms or molecular
entities to grow particles where the growth is controlled. This latter approach
is far more popular and its advantage is that particles with comparatively less
defects and more homogeneous compositions.134 This chapter focuses on
current literature on several different approaches that come under the above
two major nanoparticle synthesis methods, and emphasis is on a method
developed in our laboratory which has been versatile to make novel
nanomaterials from almost any solid substance.

Scheme 3.1 Major synthetic strategies used in nanoparticle synthesis

Two major sub-divisions of the bottom-up approach include liquid phase
and vapor phase syntheses. The liquid phase methods include co98

precipitation of nanoparticles from their corresponding solution precursors,135
the sol-gel method136 and the formation of microemulsions.137 On the other
hand, in the vapor-phase method, the precursors are in the vapor phase, and
they are thermodynamically unstable relative to the corresponding solid-state
products, and the nanoparticles are spontaneously produced from the gas
phase.138
Until recently, there have been no general methods for the synthesis of
nanoparticles, each requiring its own approach to be developed and
optimized. One major challenge in this field is the synthesis of nanoparticles
consisting of proteins and nucleic acids with controlled size and size
distributions. A general and simple approach for nanoparticle synthesis, which
is applicable to a wide variety of organic, inorganic, biological and polymeric
nanomaterials is lacking. Developing a simple, efficient, and versatile method
of nanoparticle synthesis is important for rapid progress in nanochemistry and
nanoscience.
Therefore, we attempted to develop a general approach to synthesize wide
range of nanoparticles from proteins, nucleic acids, inorganic salts, transition
metal complexes, small organic molecules and organic or inorganic polymers.
The basic premise of our approach is that precipitation of a material in
microscopic reactors can form nanoparticles, rapidly and reproducibly. Our
hypothesis is that the particle size depends on the concentrations of the
reagents used and the solubility product of the nanomaterials. Such a general
method is of high importance to access a wide range of nanomaterials for use
in practical applications or for fundamental studies. In this chapter, we
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describe an approach, which will be interlaced with other related approaches
for the synthesis of a wide range of nanoparticles from readily accessible
precursors.
In simple terms, our strategy is to contact droplets of a homogeneous
solution of one precursor with a bulk liquid phase of a second precursor such
that rapid precipitation occurs when the droplets of one reagent contact the
liquid surface of the other reagent (Figure 3.1). The resulting particles, their
growth rate and size depend on the concentrations of the nutrients, solubility
product of the precipitated chemical species, the pH of the reaction medium,
temperature and electrolyte concentrations etc., For example, contacting
droplets of an aqueous solution of met-hemoglobin with an organic solvent
such as methanol or acetonitrile, resulted in the rapid formation of protein
nanoparticles, described later in detail.
In contrast to our approach, protein nanoparticles were prepared using
supercritical fluids, emulsification or freeze-drying methods, where more
complicated instrumentation or methodologies are required.139 The current
method is simple, does not involve supercritical fluids which are not commonly
available in most research laboratories, does not require freeze-drying, or
surfactants which could denture sensitive biomolecules. Using our approach,
nanoparticles of a variety of materials including DNA, proteins, metal
complexes, organic molecules and metal salts have been prepared, for the
first time, under simple experimental conditions. We envision that DNA and
protein-based nanoparticles, in particular, will find new applications in drug
delivery,140 nanomedicine,141 biocatalysis,142 and biomarker detection.143
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3.2.1. Bottom-up Synthesis of Amorphous Nanoparticles
The main theme of bottom-up approach is that two or more reagents
can be brought together to react in a microenvironment to rapidly achieve
supersaturation of the desired solid, which ensures the formation of nuclei and
subsequent growth on the surface of these nuclei. The particle growth, when
controlled carefully, would stop where the free energy of the particle surface
equals that of the solid formation, and the growth stops. Alternatively, one
could also introduce growth terminators, which arrest the particle growth, and
the end result is the formation of nanoparticles. By controlling the reaction
conditions, concentrations and other parameters, one could produce the
nanoparticles in high yields, very efficiently. This strategy can be applied
equally well either the vapor phase or in the liquid phase, and these two
approaches are described in detail, next.
3.2.2. Vapor phase synthesis methods
As explained above, nanoparticles have been made in the gas phase by
chemical or physical processes, using a strategy analogous to those of the
solution methods. When experimental conditions are created in such a way
that vapor phase mixture of reagents is thermodynamically unstable relative to
the formation of solid materials, nanoparticles can be formed. This process
includes physical supersaturation or chemical supersaturation where the
precipitation progresses as a function of reaction conditions and time.
Homogeneous nucleation of particles occurs at saturation conditions and
supersaturation results in the reaction of vapor phase reagents on the surface
of the nucleus and induce particle growth. Under a high degree of
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supersaturation, followed by immediate quenching of the reaction produces
homogenous, small particle preparations from a variety of vapor precursors.144
The most common method to achieve supersaturation conditions in the
gas phase is to heat the solid to high enough temperature to form the vapor,
and then mixing of the vapor with a cold gas to suddenly reduce vapor
temperature. This method is commonly used in the preparation of metal oxide
nanoparticles in the vapor phase. Metals are evaporated and a reactive gas
such as oxygen introduced as the cold stream in order to produce metal
oxides of the evaporated metals.145
Depending on the method used to evaporate the solid, the above method
has been further modified using pulsed laser, charged electrode made of the
metal of interest, and sputtering of metal with a beam of inert gas ions.
Sputtering is a method of vaporizing materials from a solid surface by
bombardment with high-velocity ions of an inert gas, e.g. Ar or Kr, causing the
ejection of atoms or atomic clusters into the vapor phase.146
In an alternative method where the nanoparticles are created from suitable
precursors, supersaturation is achieved in the gas phase by using liquid or
vapor reagents. When these are allowed to react at sufficiently high
temperatures, in the gas phase, the products condense to produce the
desired nanoparticles. This approach was used to successfully produce SiO2
nanoparticles, in which the thermal decomposition of silane gas at high
temperature produces non-agglomerated single crystalline spherical particles
with diameters below 8 nm.147 This method has been further improved to
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produce composite encapsulated silica particles. In this way, SiCl4 was
reacted with Na vapor to produce NaCl encapsulated to Si-particles.148
An important extension of the vapor phase synthesis is the flame
synthesis and it is the most widely used approach to produce nanoparticles in
large quantities due to its cost effectiveness and process versatility. In flame
reactors, the energy of the flame is used to drive chemical reactions of
precursors to produce clusters, which grow larger and/or coagulate at high
temperatures to produce nanoparticles of the desired size. Generally, there
are two different routes to obtain nanoparticles, namely ʻFlame Spray
Pyrolysisʼ and ʻFlame Spray Hydrolysisʼ. Al2O3 nanoparticles are produced by
the pyrolysis method where anhydrous aluminum chloride powder is
vaporized and injected long with an inert gas into an oxy-ethylene flame. At
very high temperatures, 2000°C, aluminum chloride salt decomposes in the
flame into hydrogen chloride (HCl) and Al2O3 particles. This method could
produces 10-30 nm particles.149
In contrast to the pyrolysis method, the hydrolysis approach uses liquid
precursors, which are supplied by a syringe pump and atomized with oxygen
to produce a fine spray. Evaporation of the liquid reagent and ignition of the
spray is initiated by a small ring flame, and the resulting combustion reaction
produces nano-sized particles. One example of this approach is the
production of cerium oxide nanoparticles from liquid precursors.150
Instead of delivering the nanoparticle precursors into a hot reactor as a
vapor to produce the nanoparticles, one alternative method has been to
nebulize the liquid precursor, and directly inject the very small liquid droplets
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that are produced by the nebulizer into the flame. This method is often
referred to as aerosol decomposition or droplet-to-particle conversion. In this
technique, aqueous solutions of metal salts are first atomized into small
droplets, which are then heated to high temperatures to become solid
particles. The average diameter of the nanoparticles produced by this method
depends on a number of experimental conditions such as the original droplet
size and the solute concentration in the liquid that is nebulized. The atomizers
needed for the nebulization of the liquid precursors could be twin-fluid or
ultrasonic nebulizers that produce droplets with average diameters in the
range of several microns. This method has been successfully used to
synthesize cubic, 10 nm ZnS nanoparticles.151
Instead of heating the precursor reagents to produce the nanoparticles
in the gas phase, methods are developed to react the precursors at room
temperature. Crystalline ZnSe nanoparticles, for example, were synthesized
by this method, where vapors of (CH3)2Zn:N(C2H5)3 have been reacted with
H2Se in H2. A counter jet reactor maintained at a pressure of 120 Torr and
room temperature has been used to produce these selenide nanoparticles.152
The Liquid Phase Methods
Using our novel approach, we prepared multiple types of nanoparticles, for
the first time, under ordinary experimental conditions. Our observations in this
context are described below, and the data clearly demonstrate the versatility
of the synthesis to access a variety of nanoparticles under simple
experimental conditions, which are widely available in most laboratories.
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Figure 3.1 Schematic diagram (A) and a photograph (B) of the particle synthesizer
used in the current studies. The nitrogen jet produces a mist of solution of reagent 1
leaving the tip of the hypodermic needle, and the droplets are brought in contact with
solution of reagent 2. Precipitation occurs rapidly as the droplets contacted the liquid
surface, the resulting suspension of the nanoparticles was transparent, and the
nanoparticle suspensions were stored at 4 ˚C until further used. (C) Photograph of
particle synthesizer used in the syringe method. Syringe pump produces a constant
flow of reagent 1 with a rate of 2 mL min-1. Precipitation occurs when the reagent 1
comes in to contact with reagent 2 under vigorous stirring.
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3.3. Experimental
3.3.1. Materials.
The metal salts, ZrOCl2, calcium chloride, sodium carbonate, magnesium
chloride, zinc sulfate, bovine hemoglobin, calf thymus DNA, anthracene,
sodium

phosphate,

o-methoxyphenol,

hexammineCo(III)

chloride

and

hydrogen peroxide (analytical grade) were purchased from Sigma-Aldrich (St.
Louis, MO).
3.3.2. General Synthesis of Amorphous Nanoparticles
A solution of protein or polymer (Solution A) in appropriate solvent was
pumped by a Fisher Mini peristaltic pump, using 1/16 inch Tygon tubing and
gauge 23 hypodermic stainless steel needle and injected into a fast lowing
nitrogen stream (40 psi) to form a fine mist. The nitrogen stream was
generated from a second stainless steel needle (gauge 23) oriented at 90° to
the needle carrying solution A. A fine mist of reagent A was generated by this
apparatus, and these microdroplets are brought in contact with a liquid
solution of reagent B, where the solvent for reagent B is chosen carefully such
that the desired solid is precipitated. This contact of the precursor solutions at
the microscale resulted in rapid formation of the corresponding nanoparticles.
The principle of micromixing was also achieved by injecting a fine stream
of one reagent into a well-stirred stream of another solution (Figure 3.1C). The
rapidly flowing solutions disperse the nutrients rapidly so that nanoparticle
formation can be facilitated. In this method, reagent A was prepared under the
same conditions as in the spray method, and the solution injected at a specific
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flow rate into reagent B which is being stirred at a constant speed. By
adjusting the injection rate of reagent A as well as the stirring of the reagent
B, rapid formation of nanoparticles achieved. A major advantage with the
syringe method over the spray method is that the former can be applied for
high throughput synthesis of nanoparticles. By using a syringe pump with
multiple outlets and multiple reaction chambers, a small library of
nanomaterials can be generated, simultaneously.
3.3.3. Synthesis of Nanoparticles of Biological Macromolecules
A solution of the met-hemoglobin (Hb, 0.1 mg, 2 ml, pH adjusted to 7.0,
reagent A), for example, was sprayed onto an organic solvent (methanol, 20
ml, pH adjusted to 7.0, reagent B). Since water is completely miscible with
methanol and Hb is insoluble in methanol, immediate precipitation of the
protein occurred when the two reagents mixed. The particle size and size
distribution were measured by dynamic light scattering, immediately after the
synthesis, and particle size controlled by adjusting Hb concentration. Similar
approach was used to prepare nanoparticles of glucose oxidase and calf
thymus DNA (CT DNA). Samples were stored at 4 ˚C, for further
characterization and use.
3.3.4. Synthesis of Zr(HPO4)2 Nanoparticles.
The above method was tested for the synthesis of a number of other
nanomaterials, which were not reported earlier. For example, nanoparticles of
Zr(HPO4)2 were prepared where reagent A consisted of an aqueous solution
of ZrOCl2 (20 mM, 2 ml deionized water (DI)), and reagent B was a solution of
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Na2HPO4 (20 mM, 20 ml DI, pH adjusted to 8.0) placed in a (60 x 35 mm)
glass beaker and stirred to form a deep vortex halfway down the solution.
After the particle synthesis, pH of the reaction mixture was adjusted to 7.2 by
the addition of appropriate volume of Na2HPO4 (500 mM, 2 ml DI, pH 7.2).
Nanoparticle suspensions were examined immediately after preparation by
dynamic light scattering and stored at 4 °C for further use. Concentrations of
the stock solutions, 5-20 mM ZrOCl2 and 5-20 mM Na2HPO4 and the pH of
Na2HPO4 solution (pH 5.0, 6.0, 8.0 or 10.0) were varied to examine the
influence of pH on the size and size distributions of the nanoparticles. For the
synthesis of Zr(HPO4)2 (abbreviated as nZrP) nanoparticles, names of the
preparations are denoted by a prefix which indicated concentration of the
metal salt in reagent A and a suffix which indicated the pH of reagent B. For
example, 20ZrP-10 indicated the sample synthesized with 20 mM ZrOCl2
contacted with the phosphate solution at pH 10.
3.3.5. Synthesis of Other Nanoparticles.
The

above

approach

was

used

to

prepare

nanoparticles

of

hexammineCo(III) chloride (CoHA), polyvinyl alcohol (PVA) and polyacrylic
acid (PAA) by using appropriate solvents. Particle synthesis resulted in clear
suspensions, while physical mixing of the bulk solutions of the two reagents
(reagent A and B) resulted in visible precipitates of macroscopic materials.
The preparations were further examined by selected physical methods,
described below.
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3.3.6. Scanning

Electron

Microscopy

(SEM)

and

Powder

X-ray

Diffraction.
Scanning electron micrographs were imaged on a Leo/Zeiss 982 digital
field emission electron microscope interfaced with a Tracor Northern 30 mm2
beryllium window detector and a model 2000 spectral analysis system.
Nanoparticle suspensions were exhaustively dialyzed against deionized water
to remove dissolved salts, and a few microliters of the solution dried on Au/Pd
plated silicon wafers on Al stubs. Samples were then coated with Au and SEM
images captured in digital format.
Nanoparticles were dialyzed, in specific cases, against deionized water,
and samples have been dried with N2 to record powder X-ray diffraction
patterns by a Scintag Model 2000 diffractometer using nickel filtered CuK!
radiation. XRD of nZrP (ZrP nanoparticles) indicated very broad peaks, typical
of amorphous materials. Although there are numerous methods known for the
synthesis of nanomaterials, there are only a limited number of approaches to
make nanoparticles from inorganic salts

153,154

such as metal phosphates and

phosphonates, carbonates, sulfates and organic molecules
metal complexes.

158,159

155,156,157

transition

Current approach provides a general method for their

synthesis.
3.3.7. Dynamic Light Scattering (DLS).
Nanoparticles were sized using a Precision Detectors (Varian Inc.,)
CoolBatch+ dynamic light scattering apparatus using a 5 x 5 mm square
cuvette, 658 nm excitation laser source with a 90° geometry for the excitation
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and monitoring optics. Samples were routinely filtered with a 0.2 micron filter
prior to analysis to remove dust particles and any large aggregates. Often, the
samples were transparent and did not indicate such aggregates.
3.3.8. Circular Dichroism (CD) Studies.
The CD spectra of biological samples (CT DNA and proteins) were
recorded on a JASCO J-710 spectropolarimeter interfaced with a Dell Optiplex
personal computer by using software from JASCO. Solutions containing 0.6
mM protein or DNA samples were placed in a quartz cuvette. The protein
spectra were recorded in the 190-260 nm region (0.05 cm path length) while
the spectra of the DNA samples were recorded in the 200-300 nm region (0.1
cm path length). The operating parameters of 1 nm bandwidth, sensitivity of 5
or 20 millidegrees and response time of 4 s were used to average up to 8
scans for each sample and the data plotted using Kaleidagraph 3.0.
3.3.9. Activity Studies.
Peroxidase-like activity of Hb nanoparticles (nHb) and Hb was examined
on a HP 8453 UV-vis spectrophotometer, as previously described [19]. Briefly,
nHb or equivalent suspension was mixed with 5 mM o-methoxyphenol, 0.5
mM H2O2 and product absorbance at 470 nm was measured as a function of
time. Specific activities (with respect to the enzyme concentration) were
determined using the initial rates calculated from the data collected during the
first 100 seconds of the kinetic traces.
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3.4. Results and Discussion
The above approach was tested with a variety of reaction schemes
(Scheme 3.2) to obtain the corresponding nanoparticles, many of which are
produced for the first time. The two requirements for the success of the above
approach are: (1) the nanoparticles should be produced by precipitation from
two or more liquid precursor solutions; and (2) the solvents chosen for
reagents A and B should be miscible over the concentration range required
for the successful synthesis of the particles. These requirements are very
broad, and a number of precipitation reactions, both physical precipitation and
chemical precipitation, are amenable for this strategy. Therefore, a large
number of materials can be readily converted to their corresponding solutions
and the corresponding molecular units assembled into nanoparticles, under
mild, benign conditions. This bottom-up approach is of high synthetic value,
and the versatility of the above approach has been verified by the successful
synthesis of a large variety of nanoparticles.
The nanoparticle size, size distributions, particle stability, particle surface
capping, and chemical or enzymatic activities of nanoparticles were assessed
by suitable methods. In most instances, nanophases of the materials were
synthesized for the first time, and they have been characterized to confirm
their identity. Interestingly, nanomaterials of biological materials were
produced in organic solvents, and despite the presence of organic solvents,
these biomolecules retained their structure and function to a significant extent.
Thus, a convenient, versatile, benign and inexpensive method has been
developed to produce nanoaprticles in large quantities. Details of the
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synthesis of the nanoparticles by the spray method are illustrated with several
examples in order to illustrate the versatility of the method.
1. Insoluble inorganic

ZrOCl2 (aq)

RPO(OH)2 (aq)

Zr(RPO3)2.nH2O(s)

solid
2. Water soluble
metal complexes
3. Biological
macromolecules
4. Organic polymers

5. Small organic
molecules
6. Bio polymers

Ethanol
Co(NH3)6Cl3

Co(NH3)6Cl3 (s)

(aq)

CH3OH

Hemoglobin (aq)

Polyvinyl alcohol (ethanol)

Anthracene (DMF)

DNA (aq)

DI

DMF

Hemoglobin (s)

DI

Polyvinyl alcohol (s)

Anthracene (s)

DNA (s)

Scheme 3.2 Types of reactions used for the synthesis of a variety of nanoparticles by
the current approach, and their chemical identities. The subscript (s) indicate the
solid phase of the product produced.

3.4.1. Nanoparticles of metal salts

i. Synthesis of Zr(HPO4)2 Nanoparticles.
The spray method was tested for the synthesis of a number of other
nanomaterials, which were not accessible until now. For example,
nanoparticles of Zr(HPO4)2 were prepared where reagent A consisted of an
aqueous solution of ZrOCl2 (20 mM, 2 ml deionized water (DI)), and reagent B
was a solution of Na2HPO4 (20 mM, 20 ml DI, pH adjusted to 8.0) placed in a
(60 x 35 mm) glass beaker and stirred to form a deep vortex halfway down the
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solution. When the fine mist of the metal ion solution was contacted with the
phosphate solution, rapid precipitation ensued but the particles were not
visible to the naked eye.
Immediately after the synthesis, the metal phosphate particles were
stabilized by adjusting the pH to 7.2 and the ionic strength raised by the
addition of appropriate volume of Na2HPO4 (500 mM, 2 ml DI, pH 7.2).
Without the addition of the buffer, the particles agglomerated over certain time
period but in the high ionic strength medium, they have been stabilized for
much longer times.
Nanoparticle suspensions were examined immediately after preparation by
dynamic light scattering and they have been stored at 4 °C for further use.
Concentrations of the stock solutions have been varied, 5-20 mM ZrOCl2 and
5-20 mM Na2HPO4 and the pH of Na2HPO4 solution has been varied (pH 5.0,
6.0, 8.0 or 10.0) to evaluate the influence of pH on the size and size
distributions of the nanoparticles
The particle size, as measured by DLS (Figure 3.2A), varied from 20 to
200 nm, and a large variety of particles were produced under specific reaction
conditions. Particle size depended directly on the reagent concentrations, and
higher concentrations gave larger particles. Particle size also depended on
pH, in specific cases. For example, the size of nZrP decreased with increase
in pH of reagent B, and this observation provided an additional handle to
control particle size. Amorphous ZrP nanoparticles are produced for the very
first time by this simple approach, and ZrP nanophases are expected to
facilitate the design of novel biocatalysts. Since the crystalline, layered form of
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ZrP has been shown to stabilize numerous proteins and enzymes,160 the nZrP
provides new avenues to stabilize proteins while providing a novel platform for
the application of protein bound nZrP particles.
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A

B

C

Figure 3.2 (A) DLS plot of nZrP synthesized at pH 10 showing the particle size of 6070 nm in radius, (B) XRD data of nZrP samples prepared under specific conditions,
as marked: 5nZrP-8 (nZrP made with 5 mM ZrOCl2 and 5 mM Na2HPO4 at pH 8),
20nZrP-10 (nZrP made with 20 mM ZrOCl2 and 20 mM NaH2PO4, pH 10), and !-ZrP
(C) SEM image for nZrP showing nearly spherical particles with the size of 60 nm in
radius.
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The shape and morphology of nZrP were examined by recording the SEM
images of the particles, and one of the images of nZrP is shown in Figure
3.2B. The particles are nearly spherical, in all cases examined. The particles
appeared to be amorphous, not crystalline. This inference from the SEM
images is corroborated by powder XRD data of nZrP (Figure 3.2), which
lacked any characteristic reflections of !-ZrP or any other crystalline phases.
The SEM images of other nanoparticles preparations of amorphous ZrP
appeared similar, only the size varied depending on the reaction conditions
and pH of the medium used. But all nanomaterials retained the common
features of near-spherical shape and amorphous nature.
Particle sizes estimated from the DLS data roughly agreed with the sizes
that are inferred from the SEM images. The DLS data Figure 3.2A for
example, obtained for zirconium phosphate nanoparticles (20ZrP-10)
indicated average hydrodynamic radius (RH) of 30-50 nm and there was only
a minor variation of the radius. RH of nZrP depended on the pH of reagent B,
as well as the concentrations of the reagents A and B For example, the
particle size decreased with increase in pH from 8 to 12, at a given
concentration of ZrOCl2 (20 mM), and at constant pH it increased with the
concentration of ZrOCl2. The particle sizes, in general, ranged from 20 to 200
nm, depending on the reaction conditions and the nature of the materials
used. The ranges of particle sizes obtained for each preparation were narrow,
highly reproducible and varied only marginally (5-10%) from batch to batch.
Particle sizes are tuned from nanometers to sub-micrometers, depending on
the reaction conditions.
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The spray and the syringe methods provided unique opportunities for the
synthesis of unconventional nanomaterials, for the first time. For example, the
spray approach was used in our laboratory to prepare nanoparticles of
hexammineCo(III) chloride (CoHA) which have never been produced before.
Synthesis was carried out using an aqueous solution of CoHA, which was
prayed on to ethanol to produce the metal complex nanoparticles (nCoHA)
having the size of 120 nm. Nanoparticles of transition metal complexes are of
particular interest as drug delivery vehicles, anti cancer agents or for practical
applications where the redox activity or the spectral characteristics of the
transition metal ion is of interests.
The nCoHA particles have been characterized by a battery of physical
methods, which included DLS, microscopy and optical spectroscopy. The DLS
for example, indicated the formation of near–uniform particles of radius 60 nm
(Figure 3.3A), and the particles indicated extensive stability at oom
temperature. The SEM micrographas of the same batch of samples (Figure
3.3B) showed that the particle size is in agreement with the DLS data and
particles are spherical with no distortions in their shape. In a similar manner,
the absorption spectrum of the sample from 250–600 nm range (Figure 3.3C)
indicated the characteristic peaks of CoHA, which are completely in
agreement with the aqueous solutions of the metal complex. Therefore, the
nanoparticles of this metal complex are essentially retain the molecular
properties but produced in the form of spherical particles.
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Figure 3.3 (A) DLS plot of nCoHA synthesized in ethanol showing the hydrodynamic
radius of 60 nm, (B) SEM image showing the morphology of the nanoparticles (C)
Absorption spectrum of nCoHA (red dashed line) and CoHA (blue solid line).
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3.4.2. Nanoparticles of organic molecules
As pointed our in the previous section, the nanoparticle synthesis
methodology described here can also applied for the synthesis of small
organic molecules. The simple criteria are that the materials be soluble in one
solvent and insoluble in another, where both solvents are completely miscible
under the reaction conditions. These conditions can be readily established for
a number of organic substances, and hence, the corresponding nanomaterials
can be readily produced by inexpensive, rapid and efficient methods.
Nanoparticles of the polycyclic aromatic hydrocarbon, anthracene for
example, were produced by spraying a solution of the hydrocarbon in DMF
onto the surface of water. Since the hydrocarbon is insoluble in water and
DMF is miscible with water, the hydrocarbon molecules are quickly
precipitated from the supersaturated solution. This process triggered the
growth of the corresponding nanoparticles, very rapidly and efficiently. The
suspensions of the hydrocarbon in water were clear and transparent to the
naked eye, and formation of nanoparticles has been confirmed by DLS data.
For example, the size of the anthracene nanoparticles (nAnthracene) obtained
in our laboratory has been found to be 100-120 nm, and these particles are
considerably smaller and amorphous than the anthracene nanoparticles
reported earlier.161 These new nanomaterials provided novel opportunities for
practical applications.
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Photophysical properties of the anthracene chromophore present in these
nanoparticles are examined by absorption and fluorescence spectroscopy,
and these have been compared with the corresponding spectra of anthracene
solutions (Figure 3.4B and C, blue solid line), as described below, in detail.
The nAnthracene particles, suspended in water, indicated broad absorption
bands Figure 3.4, red dashed line, which are characteristic of ground state
aggregates162 present in the particle. This is not surprising given the fact that
these are amorphous solids derived from the anthracene chromophore. This
broadening is a direct evidence for the formation of the nanoparticles, since
the absorption spectrum of anthracene dissolved in DMF indicated sharp
features (Figure 3.4B solid line). In addition to broadening, there has also
been the red shifting of the absorption bands with the nanoparticles and this
observation is consistent with the presence of ground-state aggregates of
nAnthracene.182 Formation of such aggregates or interactions between
chromophores is also evidenced from the corresponding fluorescence spectra
(Figure 3.4C).
The fluorescence spectra of nano-Anthracene particles are consistent with
the above premise that the anthryl chromophores are in close proximity and
that they interact with each other, as they are embedded in a particle. The
fluorescence spectrum of the nanoparticle suspensions in water, for example,
indicated a broad emission band centered around 410 nm (Figure 3.4 C
dashed line). The peak is considerably red-shifted with respect to the
fluorescence spectrum of anthracene in an organic solvent such as DMF
(Figure 3.4C, solid line). The red-shifted fluorescence spectrum of
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nAnthracene suspension is consistent with the formation of excimers,
complexes of the ground state with the excited state, or ground-state
complexes, which emit at much longer wavelengths than the corresponding
isolated chromophores. Thus, the red shift in the absorption is consistent with
the red shifted fluorescence and such red shifted fluorescence of nAnthracene
has not been observed before.

182

The structured emission of nAnthracene,

however, is intriguing and this aspect needs further work.
3.4.3. Nanoparticles from synthetic polymers.
Nanoparticles of poly(vinyl alcohol) (PVA) and poly(acrylic acid) (PAA) have
been synthesized by the spray method, where two miscible solvents have
been used to precipitate the polymer from its solution. For example, PVA was
dissolved in warm ethanol, and precipitated when sprayed onto the surface of
deionized water, and the resulting polymer suspensions were totally clear to
the naked eye. Note that PVA is highly insoluble in water and if the
nanoparticles are not formed, it would have produced visible precipitates. The
nanoparticles were indeed confirmed by DLS measurements, which indicated
a particle size of 50-70 nm (Figure 3.4A). Using a similar strategy, PAA
nanoparticles were produced when an aqueous solution of the polymer has
been sprayed onto DMF, and this resulted in the rapid formation of clear
suspensions of the polymer. The DLS data indicated a particle size of 35-55
nm, while physical mixing of the bulk solutions of the two reagents (reagent A
and B) resulted in visible precipitates of macroscopic materials. Thus, the
spray method described here appears to be versatile, inexpensive, and rapid
and requires no special equipment.
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Figure 3.4 (A) DLS plots of nPVA showing the sharp distribution of particles with the
hydrodynamic radius of 50 nm (B) nAnthracene (C) The absorbance spectrum of
anthracene (1 mM, in DMF) and nAnthracene (0.3 mM, water) suspensions (D) The
emission spectrum of anthracene (1 mM, 396 nm excitation, DMF) and nAnthracene
suspensions (0.3 mM, 396 nm excitation, water)
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3.4.4. DNA Nanoparticles
Formation of compact DNA structures including DNA nanoparticles
received considerable attention in recent years163 due to the central role of
DNA in biological systems as well as its application in gene delivery and DNA
vaccines. The current models of DNA transfection with particular vectors
suggest that the long DNA molecule collapses into compact particles in the
presence of vectors, and the particles may contain only a few molecules per
particle.164 Synthetic methods for the preparation of DNA nanoparticles may
use condensing reagents such as metal ions, alcohols, strongly basic
proteins, crowded polymers, liposomes or cationic polyamines. Other
methods of synthesis may include spray freeze-drying, photocrosslinking, and
sonochemical synthesis, methods that are already described.
The principle behind the use of agents for DNA nanoparticle synthesis is
that neutralization of the excess negative charge on the DNA backbone would
collapse the molecule into a more compact structure and this particle will be
more conducive for delivery into the cells, when compared to the delivery of
the linear, rod-like molecule. Condensing agents are most widely used for
DNA nanoparticle synthesis and based on the type of condensing agent and
the reaction conditions, the particle sizes range from 20 to 150 nm.
Lipopolyamine were also used to produce nanoparticles of plasmid DNA for
transfection studies but electron microscopy showed that these particles are
heterogeneous in size and very large in diameter.165 Modification of the
synthesis with tetradecane/ornithine, 5.5 kbp plasmid DNA molecules have
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been converted into a homogenous population of DNA nanoparticles with a
size of 35 nm.166
Spray freeze-drying of DNA resulted in 150 nm nanoparticles in the
powder form, and protective agents (sucrose, mannitol etc) were used to
stabilize the tertiary structure of plasmid DNA. However, chemical conjugation
of the protective agents with poly (ethylene imine) facilitated the synthesis of
nano DNA with significant improvement in the retention of plasmid DNA
structure. Optimum DNA:PEI ratio was found to be 3 to 1, while maintaining
the particle size and net charge, in a range suitable for immunization.167
A very interesting example of DNA nanoparticles was synthesized by the
self-assembly method where metal ions and bidentate ligands have been
used in the self-assembly. Monodisperse DNA nanoparticles were prepared
by this assembly method, where Pd(II) ions and bidentate ligands
functionalized with oligonucleotides were used to produce the DNA
nanoparticles. These particles indicated well-defined, densely arranged
oligonucleotide chains, 24 chains and 12 Pd(II) metal ions per particle. These
nanospheres recognize complementary sequences of DNA and selectively
form hydrogen bonds with complementary bases. These could form novel
recognition platforms for DNA recognition in aqueous media.168
The DNA nanoparticles were synthesized via covalent conjugation169 as
well as by sonochemical methods.170 In the latter approach, a mixture of DNA
sample and a long chain hydrocarbon or soya oil were sonicated to produce
the nanoparticles. The particle shape was spherical, as seen in SEM images,
and the particle size observed by DLS varied between 300-500 nm.
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Nanoparticles of long chain nucleic acids are prepared by the spray
method in our laboratory, for the first time, and the resulting nanoparticles
have been evaluated by spectroscopic methods. An aqueous solution of calf
thymus DNA (CT DNA) was sprayed onto acetonitrile, and CT DNA has been
precipitated rapidly as the DNA is insoluble in the organic solvent while water
was completely miscible with acetonitrile. This simple approach readily formed
small nanoparticles, as evidenced by DLS (~20 nm radius). The CT DNA
nanoparticles (nCT DNA) are formed very rapidly, and the current approach is
much simpler than the lipopolyamine condensation method reported earlier.
In contrast to the earlier methods, the nCT DNA particles produced in our
studies retained the DNA secondary structure in the right handed B-form to a
significant extent, despite the presence of the organic solvent.171 The double
helical structure of the nucleic acid was examined using UV CD spectra
(Figure 3.5, dashed line), where the observed spectrum is nearly
superimposable with the CD spectrum of CT DNA dissolved in aqueous buffer
(Figure 3.5, solid line). The reason for the extensive retention of the UV CD
spectra or the extensive retention of the right-handed helical conformation of
DNA,172 could be due to the sequestration of the DNA within the nanospheres,
where the DNA molecule is shielded from the solvent by the external
molecules. This aspect may be quite significant, because the DNA
nanoparticles with well-defined structure, free of polyamines and lipids, or
other excipients could be useful in non-viral vector based gene delivery
applications.
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B

A
A

Figure 3.5 (A) DLS plot of nCT DNA synthesized in methanol, (B) The deep UV CD
spectrum of nCT DNA particles (180 µM base pairs) suspended in acetonitrile
(dashed line). The CD spectrum of CT DNA (180 µM base pairs, solid line) dissolved
in phosphate buffer (10 mM phosphate, pH 7) is nearly superimposable on that of the
spectrum obtained with nCT DNA particles suspended in the organic solvent.
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3.4.5. Synthesis of protein nanoparticles
Human serum albumin (HSA) nanoparticles, for example, are previously
produced by the emulsion method. In the emulsification synthesis, an
aqueous solution of the protein is turned into an emulsion at room
temperature in plant oil. The sample is homogenized and highly dispersed
droplets are produced with a high-speed mechanical stirrer. The protein-oil
emulsion is then added drop wise to a high volume of pre-heated oil (over
120°C) and rapid evaporation of water from the emulsion produces protein
nanoparticles. This approach was used to synthesize HSA nanoparticles, and
it resulted in a narrow distribution of particle size (500-700 nM).173 Three major
disadvantages of the emulsion method are that, (1) it requires the use of
organic solvents which tend to denature proteins and render them inactive, (2)
the exposure to high temperatures which can denature the delicate structure
of most proteins, and (3) the need to remove the oil used in the preparation.
Under these conditions proteins are usually denatured irreversibly, and data
also show that the synthesis is limited to protein nanoparticles of size 500 nm
and greater.174
Solvent desolvation method has been used as an alternative to the
emulsification method for the protein nanoparticle synthesis. In this method, a
desolvating agent is added to an aqueous protein solution, followed by
stabilization of the particles by crosslinking of the lysine side chains present
on the protein surface with the bifunctional glutaraldehyde. This approach was
successfully used to produce soy protein nanoparticles where ethanol was
used as the desolvating agent, and more than 75% equivalent of
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glutaraldehyde has been used for crosslinking. Due to the presence of
ionizable groups on the surface of the protein, the protein nanoparticles are
expected to have a net charge at most solution pH conditions, and the charge
could be an important parameter in controlling the stability of the particle. The
zeta potential of the above soy nanoparticle dispersion was − 36 mV, and
these particles indicated moderate stability. The soy nanoparticles were
nearly spherical with smooth surface features.175 One disadvantage of the
desolvation-crosslinking approach is that the denaturing conditions used here
could disturb the native structure of the protein and adversely influence the
biological activity of the protein particles.
An alternative, milder approach for the synthesis of protein nanoparticles is
the spray-freeze drying process, where an aqueous protein solution is
sprayed into a cold vapor, over a cryogenic liquid to form droplets. The protein
solution droplets freeze quickly while falling through the cold vapor. This
method was used to produce bovine serum albumin (BSA) and large
aggregates are formed in the absence of an excipient. However, in the
presence of Zn(II) the particles were stabilized against aggregation. Even so,
both free and Zn-complexed samples showed perturbation of native protein
structure, which is a concern if the biological activity of the protein is to be
retained.176 Cold denaturation of the protein, denaturation at the air-water
interface, and disruptions of native structure during the particle formation may
result in the loss of structure and biological activity during freeze-drying
process.

128

Supercritical fluids (SCF) provide another benign, sustainable approach for
the production of protein nanoparticles. Solvent extraction-evaporation,
solvent diffusion and organic phase separation methods are hazardous to the
environment as well as to the biological macromolecules. Therefore,
supercritical fluid technology offers an alternative to prepare nanoparticle
synthesis under mild temperatures and it can result in high purity preparations
free of organic solvents and excipients.177 For example, the protein is directly
dissolved in the SCF and the solvent is rapidly evaporated by expansion
through a nozzle so that the solute precipitates as nanoparticles.178
Supercritical CO2 and H2O, for example, are being used to prepare protein
nanoparticles and a variety of other nanomaterials.179 Nanoparticles of the
protein lysozyme was produced from DMSO and CO2 and these particles had
a size of 200-300 nm and the particles retained about 75% of lysozyme
enzymatic activity when compared to the untreated enzyme. However, the use
of CO2 as a SCF requires high-pressures and the synthesis releases large
quantities of CO2, which can have environmental impact unless captured and
recycled.180
To overcome some of the above problems, a new method was developed
for the synthesis of protein nanoparticles by the crosslinking approach. The
surface functional groups of the protein are crosslinked enzymatically during
and/or

after

the

formation

of

protein

nanoparticles.

The

enzyme,

transglutaminase (TG) can crosslink the side chains of lysine residues with
glutamine side chains. Proteins such as gelatin, albumin, collagen, fibrin,
laminin etc have appropriate side chains for this reaction and the
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corresponding

nanoparticles

were

produced.

For

example,

gelatin

nanoparticles were prepared by crosslinking acid treated gelatin with TG,
followed by the dispersion of the particles in ethanol. Average protein particle
size was found to be between 10-1000 nm depending on the protein and the
amount of TG used for the synthesis.
As illustrated above, the synthesis of protein nanoparticles with the
retention of their biological activity and native-like structure is a challenge.
Most of the above approaches also use methods that can denature the
delicate structure of most proteins and they can be expensive. Therefore, we
have used our solution spray method to synthesize protein nanoparticles,
under mild conditions, while retaining their native like structure and biological
activities. This approach is illustrated with hemoglobin (Hb) and glucose
oxidase (GO) as two typical examples. Note that both these proteins are
catalytically active and retention of their structures can be ascertained by
circular dichroism spectroscopy. Thus, both the structure as well as the
biological activity of the particle preparations can be readily evaluated to
assess the feasibility of the spray method for the benign synthesis of protein
nanoparticles.
A typical method used for the protein particle synthesis consists of the
following. An aqueous solution of Hb (0.1 mg, 2 ml DI, pH adjusted to 7.0,
reagent A), for example, was sprayed onto methanol (20 ml, pH adjusted to
7.0, reagent B) with vigorous stirring. Since water is completely miscible with
methanol and Hb is insoluble in methanol, immediate precipitation of the
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protein occurred when the two reagents were brought in contact. The particle
size and size distribution depended on the experimental conditions used.
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A

B

Figure 3.6 (A) The DLS plot (B) TEM image of nHb synthesized in methanol. The
average hydrodynamic radius observed with nHb is 100 nm, which is in agreement
with the particle size observed with TEM.
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3.4.6. Characterization of protein nanoparticles
Electron microscopy of the Hb nanoparticles (nHb) indicated very smooth
surface features (Figure 3.6B). Consistent with this picture, the DLS data
showed that nHb nanoparticles had radii in the range of 90-100 nm (Figure
3.6A) To the best of our knowledge, these are the very first reports of nHb
preparation, characterization and evaluation, and these lay foundation for
future

development

of

artificial

blood

substitutes.

After

appropriate

crosslinking of the nHb nanoparticles under benign conditions, they could be
rendered insoluble in aqueous solutions, and thereby they could be tested as
artificial blood substitutes.
Our spray approach is also tested for the synthesis of other protein
nanoparticles, and the second example is that of GO. For example, contacting
the fine mist from an aqueous solution of GO with methanol, readily produced
the corresponding GO nanoparticles (nGO) and particle formation was
confirmed by DLS. nGO had particle sizes in the range 20-50 nm and nGO
preparations were stable for days without any degradation in quality nor they
indicated any precipitation.
3.4.7. Protein nanoparticle structural studies
We also examined the secondary structure of the protein in the
nanophases by a variety of spectroscopic and biochemical methods, and
structure retention is crucial for the retention of their biological activities. The
protein secondary structures were examined by monitoring the changes in the
absorption or the circular dichroism spectra of the protein nanoparticles when
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compared to those of the corresponding protein solutions. The Soret
absorption band of nHb, for example, appeared at 406 nm Figure 3.7A,
dashed line and the peak position matched well with the absorption spectrum
of Hb dissolved in buffer (Figure 3.7, solid line). Note that the protein particles
are suspended in methanol while the native protein was dissolved in an
aqueous buffer. Despite these differences, the soret absorption band is not
disturbed; Distortion of the heme environment of Hb or denaturation of the
protein matrix around the heme would have blue-shifted the Soret absorption
peak.181 Therefore, Hb forms excellent nanoparticles with retention of structure
around the heme pocket, and the heme environment of the protein is nearly
unperturbed even when the particles are present in methanol. This result is
unusual, and we suggest that the heme protein packed within nanoparticles is
shielded from the organic solvent. This shielding, and the benign conditions
used forth synthesis and stabilization of the particles is responsible for the
retention of Hb secondary structure in the particle preparations. These protein
and

enzyme

nanoparticle

preparations

applications.
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are

promising

for

biological

B

Product absorbance

A

C

Figure 3.7 (A) The Soret absorption of nHb in methanol (red dashed line) and the
corresponding spectrum of Hb in aqueous solution (10 mM phosphate buffer, pH 7,
solid line). (B) The UV CD spectrum of nHb (red dashed line) and Hb solution (5 mM
Tris HCl, 10 mM NaCl pH 7, blue solid line) are nearly superimposable, which clearly
indicates that the native-like structure of the protein is retained in these
nanoparticles. (C) The peroxidase like activity of nHb in methanol (red dashed line, 1
µM) and free Hb in aqueous solution (blue solid line, 1 uM). Oxidation of omethoxyphenol by H2O2 was measured by monitoring the absorbance at 470 nm.
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The absorption spectra of methanolic suspensions of nGO matched
with those of GO dissolved in the buffer and the absorption spectrum of the
flavin co-factor of nGO was nearly unchanged after the particle formation and
their suspension in methanol. Again, this is the first report of the preparation
of nGO by a benign method with significant retention of protein structure as
well as activity in the nanoparticle preparations. Therefore, the newly
developed spray method can be used to prepare protein or enzyme
nanoparticles whose prosthetic groups are not covalently attached to the
peptide chain and there is no fear of loss of the prosthetic group during the
synthesis of the nanoparticles. In addition to the retention of protein structure,
retention of the overall secondary and tertiary structures of the protein are
essential for the retention of their biological activities. These structural details
of the protein nanoparticles have also been assessed.
The three-dimensional structure of the protein, and in particular its
secondary structure, is important for its biological function.182 This aspect was
assessed by recording the CD spectra of the protein nanoparticles in the deep
UV region. The deep UV CD spectrum of nHb indicated peaks at 190, 211
and 222 nm (Figure 3.7, dashed line), which is nearly superimposable on the
spectrum of the Hb dissolved in buffer (Figure 3.7, solid line). Similarly, the
CD spectra of nGO suspended in methanol and GO dissolved in the buffer are
nearly superimposable. (211 nm and 222nm peakes for nGO are not clearly
seen-see Figure 3.8) The CD data, in particular, show that the native-like
structures of both Hb and GO are retained in the corresponding nanoparticle
preparations, even though the particles were suspended in a non-aqueous,
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organic solvent, methanol. This is a remarkable outcome and indicates the
strong possibility for the retention of the biological activities of the proteinnanoparticles in organic media. Note that protein particles are stabilized for
days, when the pH of the suspension in methanol was adjusted to 7. These
protein nanoparticle suspensions are promising to examine enzyme-mediated
catalysis in organic solvents, which will be evaluated in future studies.
Activities of these suspensions at room temperature are assessed in
biochemical activity studies described below.
3.4.8. Catalytic Activities of Enzyme Nanoparticles.
Biological applications of the protein nanoparticles require that the
nanoparticles retain their activities, whatever they may be. For example, the
use of nGO for glucose sensing would require that the preparations retain
their oxidative activities to a significant extent. Similarly, the application of nHb
preparations requires that the biological function of heme function is
preserved in these particles. Peroxidase-like activity of Hb is well known, and
this provided a good measure to examine its biological activity in the
nanophases suspended in organic media.
Exposure of Hb solutions to guaiacol (1 mM) and hydrogen peroxide (0.1
mM) results in the rapid growth of the corresponding oxidation product with an
absorption peak at 470 nm. Therefore, this enzymatic reaction provided a
simple colorimetric method to assay for the biological activity of heme present
in nHb. Therefore, we examined the peroxidase-like activities of nHb
suspensions in methanol to assess the redox activities of nHb. Interestingly,
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nHb indicated the rapid conversion of guaiacol to the corresponding oxidation
product, as evidenced by the growth of product absorbance at 470 nm. The
initial rate of product formation indicated that the nHb preparations (0.3x10-3
µM-1 s-1) retained 30% of the activity (Figure 3.7C, red dashed line) of Hb
dissolved in aqueous solutions (1x10-3 µM-1 s-1, Figure 3.7,blue solid line),
even though the two catalysts were in different solvent and pH conditions.
Activity of free hemin dissolved in methanol was far less (1.03 x 10-5 µM-1 s-1),
and thereby proving that activity of nHb is not due to heme released into the
organic solvent. Recognizing that the pH of the nanoparticle suspensions
could not be buffered in methanol to a significant extent, due to the lack of
sufficient solubility of buffer salts in methanol, retention of 30% activity for the
particle suspensions is significant. Diffusion of the substrate into the
nanoparticle interior will be slow, and the substrate will not be able to
experience the Hb molecules buried in the interior or the particles. Given
these caveats, the activity data indicate that Hb retains its structure and
activity in nHb to a significant extent.
In a manner similar to nHb, the nGO suspensions also retained their
catalytic activities and they rapidly oxidized glucose to gluconic acid. The
specific activity of GO in phosphate buffer at pH 7.0 was 6.9x10-4 (µM/s)
(Figure 3.8B, blue solid line) as compared to the nGO suspensions (Figure
3.8B, red dashed line), which indicated specific activity of 4.2x10-4 (µM/s) in
methanol. Thus, there is nearly 60% retention of nGO activity even though the
solvent was changed from water to methanol, and that the latter solvent could
not be buffered well due to poor solubility of the buffer salts in methanol. Thus,
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enzyme nanoparticles can be readily synthesized under benign conditions
with significant structure retention, as indicated by spectroscopy, but
measurements of their biological activities in organic solvents pose unique
challenges. However, overcoming these challenges is perhaps worthy
because success in this area would promote the utility of organic enzymology,
an important practical area for the synthesis of numerous organic molecules
that are otherwise difficult to accomplish.
These novel examples of enzyme/protein nanoparticles may pave the way
to carry out enzyme-catalyzed reactions in non-aqueous solutions where the
hydrophobic substrates are more likely to dissolve in organic solvents than in
water. Note that this aspect is important in extending the utility of biocatalytic
activities of enzymes to hydrophobic substrates.
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A

Product absorbance

B

Figure 3.8 (A) The UV CD spectrum of nGO (red dashed line) and free GO (10 mM
Na2HPO4 pH 7, blue solid line), (B) Activity plot of nGO (red dashed line, 1 µM) and
GO (blue solid line, 1 µM) as a function of time.
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In summary, a new, general, versatile method was developed to
synthesize nanoparticles of almost any molecular or polymeric material (Table
3.1). The only requirement is that the material needs to be soluble in one
solvent and insoluble in another, while both solvents are completely miscible.
Numerous materials satisfy these conditions, and here, a number of examples
of novel nanoparticle syntheses are demonstrated. This method provides new
opportunities for the synthesis and investigation of nanomaterials, which are
not currently accessible or not accessible by simple synthetic routes.
Nanoparticle suspensions, after synthesis, were transparent and samples
were stable for weeks or months in particular cases.
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Table 3.1 The reagents used and the corresponding nanoparticles prepared. The
average hydrodynamic radii of the particles (RH) varied from 20-140 nm and
depended on concentrations of the reagents and pH of the medium, as indicated
below.
Name

Reagent A

Reagent B/Solvent

Size, [nm]

20ZrP-8

ZrOCl2 [20 mM, 2 ml]

Na2HPO4 [20 mM, 20 ml, pH 8]

100 - 140

20ZrP-10

ZrOCl2 [20 mM, 2 ml]

Na2HPO4 [20 mM, 20 ml, pH 10]

30 - 50

20ZrP-12

ZrOCl2 [20 mM, 2 ml]

Na2HPO4 [20 mM, 20 ml, pH 12]

25 - 30

20ZrCEP-8

ZrOCl2 [20 mM, 2 ml]

2-carboxyethyl phosphonic acid [20

100 - 115

mM, 20 ml, pH 8]
20ZnHPO4-10

ZnSO4 [20 mM, 2 ml]

Na2HPO4 [20 mM, 20 ml, pH 10]

60 - 70

100MgHPO4-3

MgSO4 [100 mM, 2ml]

Na2HPO4 [20 mM, 20 ml, pH 3]

40 - 50

20CaHPO4-8

CaCl2 [20 mM, 2 ml

Na2HPO4 [20 mM, 20 ml, pH 8]

20 - 40

nHb

Hemoglobin [Hb, 5 µM, 2

CH3OH [5 ml]

90 - 100

CH3OH [5 ml]

20 - 50

acetonitrile [5 ml]

~ 20

Deionized water (DI)

50 - 70

DMF [5 ml]

35 - 55

EtOH [10 ml]

60 - 80

DI [25 ml]

100 - 120

ml water]
nGO

Glucose oxidase [GO, 5
µM, 2 ml water]

nCT DNA

CT DNA [1 mM, 2 ml
water]

nPVA

Poly (vinyl alcohol) [2 ml
warm EtOH]

nPAA

Poly (acrylic acid), 2 ml
water]

nCoHA

[Co(NH3)6]Cl3 [CoHA, 10
mM, 2 ml water]

nAnthracene

Anthracene [1 mM, 2 ml
DMF]

142

3.5. Conclusions
A facile new method to synthesize nanoparticles from proteins, nucleic
acids, inorganic salts, metal complexes, organic molecules, and organic
polymers is demonstrated. The particle size is continuously tunable from ~ 20
nm to several hundred nanometers depending on the solution conditions. This
method is a significant development and provides access to a variety of novel
nanomaterials, which are hitherto unknown. The CD spectra of the
nanoparicles derived from biological samples indicated retention of native-like
structures of these sensitive molecules even when suspended in nonaqueous solvents. This aspect is critical, if the bionanoparticles are to be used
for biological applications. Samples were stabilized over months when stored
at 4 ˚C, and did not indicate any perceptible aggregation, and this aspect is
important for the long-term storage and for commercialization. Biological
activities of nHb and nGO particles were retained even though the samples
were suspended in an organic solvent and most enzymes lose their biological
activities when dissolved in organic solvents due to loss of their structure.
Nanoparticle preparations of proteins and enzymes are of major significance
for biocatalysis in non-aqueous media.
The current method is one of the first reports of a general method for the
synthesis of nanoparticles of almost any type of molecular or polymeric
materials, and this advancement might facilitate rapid progress in this
important area of nanoscience and technology. These examples supplement
literature methods, when available, but the current method is robust, versatile
and inexpensive for scale-up. In all, the current state of synthesis and
143

characterization of nanomaterials is experiencing strong growth, and practical
applications of these materials are highly promising for societal benefits and
also for fundamental investigations of the nature of these nanomaterials.
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Chapter 4.

Fluorescently-Labeled

Bioactive

Protein

Nanoparticles (Prodots) for Improved Uptake by Oral Cancer
Cells
4.1. Abstract
A simple and effective method for synthesizing highly fluorescent proteinbased nanoparticles (Prodots) and their facile uptake by oral cancer cells is
described here. Prodots made from glucose oxidase (nGO), bovine serum
albumin (nBSA), horseradish peroxidase (nHRP), catalase (nCatalase) and
lipase (nLipase) were found to be 15-50 nm wide and have been
characterized by transmission electron microscopy (TEM), circular dichroism
(CD), fluorescence spectroscopy, dynamic light scattering (DLS) and optical
microscopic methods. Data showed that the protein structure is retained and
Prodots derived from enzymes retained their catalytic activities to a significant
extent. For example, specific activities of nGO, nHRP, nCatalase and nLipase
were 80, 70, 65 and 50% of their respective original activities. Calorimetric
studies indicated that the denaturation temperatures of nGO and nBSA
increased when compared to those of the corresponding untreated proteins,
and the storage half lives of Prodots at 60 ºC also increased 4 to 8-fold when
compared to the respective proteins, stored under the same conditions.
Cellular uptake of nGO and nBSA with oral cancer cells indicated rapid uptake
within 2.0-2.5 h. Uptake was accompanied by significant blebbing of the
plasma membrane and indicated nearly uniform distribution of the particles in
the cells. The presence of nGO/glucose in the cell media enhanced the
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uptake of other Prodots, and we suggest that hydrogen peroxide induced
membrane permeability is responsible for this rapid uptake. These are the first
examples of very rapid cellular uptake of fluorescent Prodots by cancer cells.
This approach is a simple and efficient method for cellular imaging and for
protein transfection into cells.
4.2. Introduction
Synthesis of protein nanoparticles (Prodots) that are highly fluorescent,
stable, versatile and their rapid cellular uptake by cancer cells is reported
here. Currently, nanoparticles are extensively being used in a wide range of
applications

including

biocatalysis,183,184,185

drug

delivery,186,187,188,

biosensing189,190,191 and bioimaging.192,193,194 Prodots are among materials of
greatest interest essentially due to their biocompatibility, biodegradability and
amenability for surface modification. They are being extensively tested for
drug delivery applications.195 However, purely protein-based nanoparticles
that, are stable, biocompatible, benign and also strongly fluorescent for
imaging of cells with the size smaller than 20 nm are currently lacking or
adequate/limited.
Most prominent examples of nanoparticle use in cellular imaging includes
but not limited to semiconducting fluorescent nanocrystals or quantum dots
(QD),196 plasmonic nanoparticles such as gold and silver,197 inorganic
nanoparticles such as silicon198 and magnetic nanoparticles.199 These nanosized probes are designed to produce bright, photostable fluorescence,
detectable with conventional optical methods. However, all these probes
require added biocompatible surface coatings and modifications to reduce the
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toxicity and improve the solubility in aqueous media, respectively. Hence
nanoparticles synthesized from biodegradable, non-toxic and water-soluble
yet capable of emitting in a certain excitation window are important for cellular
imaging. Protein-based particles are advantageous over conventional
quantum dots as these are biocompatible, and these have the potential to
provide multiple copies of functional proteins to control cellular biological
processes directly. A general approach of synthesizing such Prodots is
described here.
Protein nanoparticles are generally prepared by freeze drying,200,201
supercritical fluid technology,202 spray drying,203 desolvation204,205,206 and
enzymatic crosslinking.207 Most of these methods require organic solvents,
drying or dehydration, which may damage the delicate structure of some
proteins/enzymes and subsequent loss in their biological activity. Though
supercritical fluid (SCF) methods use mild conditions, they mostly produce
particles in the 1-10 μm size, with wide ranges of size distributions.208 αchymotrypsin nanoparticles, for example, prepared by SCF method (size ~1
μm) retained only 10-60% of their original activity.209,210
Alternative methods of Prodots synthesis with lower sizes, higher retention
of biological activities and preferably carrying a spectroscopic tag will be
useful for biomedical and biological applications.
Controlling the size of Prodots is important, as this is one of the key factors
governing their fate in biological systems.211,212,213,214,215 Particles smaller than
10 nm are subjected to rapid renal clearance216 while particles of 10-50 nm
have the ability to distribute in intracellular and extracellular spaces without
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hindrance from the lymphatic system. Particles of 100-200 nm are captured
by the lymph nodes, while particles larger than 200 nm are concentrated in
the spleen or taken up by phagocytic cells. On the other hand, microspheres
larger than these sizes are quickly captured and removed from circulation.217
The circulation time, therefore, depends on particle size. For example, 12 nm
particles have 24.7 ± 4.0 h circulation half-life in mice while 60 nm and 125
nm particles have 16.6 ± 1.60 and 9.7 ± 0.8 h half-lives, respectively.218
Therefore, controlling the size of Prodots is critical for biological applications.
Particles produced in this study are of 10-20 nm wide, which are suitable for
cellular uptake, drug delivery, transfection and imaging, as well as
biocatalysis.
An important issue with most Prodots is tracking their cellular uptake in
real time. One approach has been to make fusion proteins with natural
fluorescent proteins and subsequently, prepare Prodots from these fusion
products.219 One drawback of this approach is the presence of the fluorescent
protein in the nanoparticle, which may not be desirable for the intended
application and may decrease the stability or interfere with biological
functioning of the protein or its folding. Another approach for tracking has
been to append a fluorescent probe to nanoparticle by covalent or noncovalent methods. For example, BSA nanoparticles (size, 100-150 nm)
embedded with an infrared-absorbing dye were prepared by desolvation,
crosslinking with glutaraldehyde, followed by solvent evaporation.220 However,
the use of organic solvents and glutaraldehyde may not be preferable for
biological applications. The current method does not use organic solvents or
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glutaraldehyde, but instead uses a general approach to produce highly
fluorescent Prodots from ordinary proteins, under benign conditions, which
are shown to be rapidly internalized by cancer cells. Furthermore, fluorescent
Prodots can be non-toxic, biocompatible, require no biophilic coatings to
passivate hot spots on their surfaces, and they may be degraded after use by
normal biological mechanisms.221,222,223,224
One important application of Prodots is imaging parts of the cell while
providing

real-time

advantageous

monitoring.

because

Imaging

multiple

with

fluorescent

chromophores

of

Prodots

desired

is

optical

characteristics can be embedded within the particles and the approach is not
limited by limited accesses to fluorescent proteins available as fusion
products.
A general approach is described here, for the synthesis of fluoresceinlabelled nanoparticles directly from several proteins or enzymes. Specifically,
GO nanoparticles (nGO), HRP nanoparticles (nHRP), catalase nanoparticles
(nCatalase), lipase nanoparticles (nLipase), and bovine serum albumin
nanoparticles (nBSA) characterized with a narrow size distribution, small radii,
and embedded with fluorescein tag, are described. Data indicated high
stability, small size (<50 nm), high degree of retention of biological
activity/structure and the rapid uptake by oral cancer cells. The presence of
nGO in the media facilitated rapid internalization of other Prodots into oral
cancer cells. The Prodots reported here could be good candidates for protein
transduction studies, cellular imaging and drug delivery applications.
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4.3. Experimental
4.3.1. Proteins and Chemicals
Glucose Oxidase (GO, Aspergillus niger), Horse Radish Peroxidase (HRP,
Equine heart), Lipase (Candida rugosa) and Dibasic Sodium Phosphate
(Na2HPO4),

Fluorescein,

Fluorescein

isothiocynate(FITC),1-Ethyl-

dimethylaminopropyl)carbodiimide (EDC) were purchased from Sigma Aldrich
(St. Louis, MO). Bovine Serum Albumin (BSA) and Catalase were purchased
from US biologicals and Worthington Biochemical Co., respectively.
4.3.2. Synthesis of Protein Nanoparticles
Protein/Enzyme solutions were prepared by stirring protein (3 mg/ml) in
0.1 M carbonate/bicarbonate buffer adjusted to pH 9. A solution of fluorescein
isothiocynate (FITC) (0.075 mg/ml: 0.2 mM) prepared in DMSO was added to
the protein solution and the mixture was stirred for 1.30 h. The pH of the
resulting solutions was adjusted depending on the pI of the protein (Table 4.1,
synthesis pHs).
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Table 4.1 pH conditions used for the synthesis of protein nanoparticles

Sample

pI of the parent protein

Synthesis pH

nGO

4.2

6

nBSA

4.7

6

nHRP

7.2

8

nLipasse

4.9

9

nCatalse

5.4

9

Finally, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (10mg/ml:
52 mM) was added to the protein/fluorescein solution and the resulting
solution was stirred over night. Samples were dialyzed against 25 kDa cut-off
membranes to remove unreacted fluorophore, EDC and urea byproducts.
4.3.3. Agarose Gel Electrophoresis
Native agarose gels were prepared by dissolving agarose (0.5% w/v)
(Sigma electrophoresis grade) in a hot solution of Tris acetate (40 mM, pH
6.5). The gel was placed on a horizontal gel electrophoresis apparatus (Gibco
model 200, Life Technologies Inc, MD) and Tris acetate (40 mM pH 6.5) was
used as the running buffer. Samples were loaded into the wells with loading
buffer (50% v/v glycerol and 0.01% m/m bromophenol blue) and
electrophoresis carried out for 30 min at 100 mV at room temperature. The gel
was stained overnight with 10% v/v acetic acid, 0.02% m/m Coomassie blue
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and then destained with 10% v/v acetic acid for an additional night. The gel
was photographed using a CanoScan LIDE 200 scanner.
4.3.4. Dynamic Light Scattering (DLS)
Hydrodynamic radius of the particles was measured by means of photon
correlation spectroscopy by using Precision Detectors (Varian Inc.,)
CoolBatch+ dynamic light scattering apparatus with a 5 × 5 mm square
cuvette, 658 nm excitation laser source with a 90° geometry for the excitation
and monitoring. Data collection was done at 26 ºC, for 1s, 5 repetitions with
60 accumulations after equilibrating the sample for 300 s. Ptodot samples and
their corresponding proteins after diluting to 0.2 mg/ml in 10 mM Na2HPO4
buffer pH 7 were routinely filtered with a 0.2-micron filter (PVDF, 13 mm,
Fisher brand) prior to analysis to remove dust particles and any large
aggregates. Precision Elucidate Version 1.1.0.9 and Precision Deconvolve
Version 5.5 were used to run the experiments and data processing,
respectively.
4.3.5. Transmission Electron Microscopy (TEM)
The nanoparticle solution (0.2 mg/mL) was applied to a carbon-coated Cu
grid (400-mesh) after making the grid hydrophilic using plasma cleaner
(Harrick PDC-32G). Aliquots of 3 µL were incubated on the grid for 60 s to
allow particle adhesion and were then blotted with filter paper (Whatman #4).
To distinguish the protein, the grids were stained with 3 µL of 1% uranyl
acetate for 30 s and then blotted again. The grids were kept for an hour to dry
and then moved directly to the microscope for imaging. All the imaging was
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done using a FEI Tecnai™ Spirit TEM with an operating voltage of 80 kV. The
micrographs were recorded in a 4 Mega Pixel AMT camera connected to the
instrument.
4.3.6. Spectral Measurements
Interaction of protein with the fluorescein was monitored by absorbance
spectra on HP 8450 diode array spectrophotometer (Varian Inc., Santa Clara,
CA) at 25 ºC. Protein nanoparticle solutions were diluted in 10 mM Na2HPO4
buffer pH 7.2 before taking any absorbance measurements. Absorption
maxima for all the proteins were recorded at 280 nm, and free fluorescein
concentration monitored at 490 nm (in 10 mM Na2HPO4 pH 7). Fluorescence
spectra were recorded on a home-built instrument interfaced with a Macintosh
mini operated by in-house software written in Chipmunk basic (V3.6.4(b8)).
Emission spectra were acquired for each sample and compared with that of
fluorescein by exciting at 495 nm. To keep the absorbance less than 1, a
short path length cuvette (1 mm × 10 mm) was used.
4.3.7. Fluorescence Quenching Studies
Solution of Prodots (nCatalase) in the presence of potassium iodide (KI)
was titrated with increasing concentration of KI and the emission for FITC at
525 nm (exciting at 490 nm) was monitored. Stern-Volmer plots was
constructed for FITC attached to nCatalase as well as free FITC and the
quenching constants (Ksv) determined from fits to the data using the equation
below:
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I0/I = 1 + Ksv [Q]
I0 = intensity at 525 nm without the quencher (I-)
I = Intensity at 525 nm in the presence of the quencher
Q = Concentration of the quencher
4.3.8. Cellular Imaging Studies
HN12 oral cancer cells were grown onto glass bottom microwell dishes
(#1.5 glass, MatTek Corporation), washed using DMEM without phenol red
and FBS (Invitrogen) and incubated in the same media with 0.3 mg/ml of
nanoparticles for 4 h to visualize internalization. Live cell imaging and
quantification were performed at 37 ºC and 5% CO2 using an inverted Zeiss
LSM 700 confocal microscope, coupled to Zen software 2010 (Carl Zeiss) and
equipped with CO2 and temperature chamber. For quantification, an area of
interest (ROI) was drawn around each cell and the average fluorescent
intensity inside of the cell was recorded at different times.
4.3.9. Enzyme Activity Studies
Activity of GO nanoparticles and unmodified glucose oxidase was
determined by a previously reported method.225 Solution of glucose (0.2 mM)
was added to a mixture of GO (1 μM), HRP (1 μM) in 10mM Na2HPO4 buffer
pH 7.2 and guaiacol (o-methoxyphenol) (5 mM) dissolved in de-ionized
distilled water. Oxidation of the substrate guaiacol to a dimeric product, which
has absorption maxima at 470 nm, was monitored as a function of time (25
ºC).
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Activities of lipase nanoparticles and unmodified lipase were determined
using p-nitrophenyl acetate (PNPA) as the substrate.226 PNPA (20 μM in 5%
acetonitrile) was added to the lipase solution (1 μM) in 10 mM Na2HPO4 buffer
pH 7.2. Absorbance at 410 nm due to the formation of the colored product, pnitro-phenoxide was recorded as a function of time. Initial rates and the
specific activities were calculated using kinetic traces within the initial linear
region of the data (first 50 seconds).
Peroxidase activity of HRP nanoparticles was determined by the reported
method with minor modifications.227 Guaiacol (2.5 mM) and H2O2 (0.5 mM)
were added to HRP (100 nM) in 10 mM Na2HPO4 buffer pH 7.2 and the
product formation was monitored at 470 nm as a function of time. The kinetic
data were used to extract initial rates and specific activities as described
above.
Activities of catalase nanoparticles were measured using the rate of
decomposition of H2O2 (20 mM). Hydrogen peroxide was added to a solution
of catalase (1 μM) in 10 mM Na2HPO4 buffer pH 7.2. Decomposition of H2O2
was monitored by decreasing the absorbance at 240 nm as a function of time.
4.3.10.

Half-lives of Nanoparticles at 60 ºC

Time taken to reduce the enzymatic activity by half of its original
activity (half-life) was estimated. Half-life of protein nanoparticles was
assessed by measuring their activity at room temperature after heating at 60
ºC in a water bath (Fisher Scientific Isotemp refrigerated circular Model 9000)
for increasing lengths of time. Half-life was obtained by plotting specific
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activities at unit concentrations of both the enzyme and substrate, as a
function of time.
4.3.11.

Differential Scanning Calorimetry

Thermal denaturation of Prodots was performed using Nano II differential
scanning calorimeter (DSC) 6100 from Calorimetry Sciences Corporation
(CSC, Utah). Native protein and protein nanoparticle solution (in 10 mM
Na2HPO4 buffer pH 7.2) was scanned using 10 mM Na2HPO4 buffer pH 7.2 as
the reference sample. The amount of heat required to increase the
temperature of a sample with respect to the reference was monitored in a
series of heating and cooling scans equilibrated at 20 ºC for 10 min and
scanned from 20 to 100 ºC at a scan rate of 2º C/min. The excess molar heat
capacities of the samples were calculated using molar masses of
corresponding proteins. Since the samples were not showing any reversible
denaturation under these conditions, model independent parameters, peak
transition temperature (Tm), the temperature where the denaturation begins
and ΔHdenaturation (integral CpdT) were extracted from the DSC data.
4.4. Result and Discussion
4.4.1. Syntheses of Protein Nanoparticles
In the current approach, (Scheme 4.1) the amino groups of the lysine
residues of proteins are coupled with FITC, followed by controlled aggregation
of the proteins and then crosslinking by EDC, under optimized reaction
conditions. Prodots are purified by dialysis to remove unreacted reagents
and/or urea by products. All Prodots suspensions were completely
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transparent and did not indicate any precipitation at any stage. Nanoparticle
formation during the reaction was monitored by dynamic light scattering (DLS,
Figure 4.1) to ensure the production of nano particles (10-20 nm). In this
context, we believe that FITC labeling induces protein clustering,228,229 which
is controlled carefully by experimental conditions and subsequently these
aggregates are chemically cross-linked to produce stable Prodots. They are
characterized by a battery of physical and biochemical methods described
below and tested for cellular uptake and imaging with oral cancer cells as
model systems.
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Fluorescently Labeled Prodot

Scheme 4.1 Synthesis of protein nanoparticles by FITC conjugation followed by EDC
coupling, where the amino groups of the lysine residues of proteins are coupled with
FITC, followed by controlled aggregation of the proteins and then crosslinking by
EDC, under optimized reaction conditions.

158

4.4.2. Agarose Gel Electrophoresis
The electrophoretic mobility of the Prodots and their corresponding
proteins are shown in Figure 4.1E. Mobility of Prodots is expected to be less
than those of the parent proteins due to their increased size. As anticipated,
nBSA (lane 2), nGO (lane 4) and nCatalase (lane 7) migrated to the positive
electrode with decreased electrophoretic mobility when compared to the
bands of the corresponding free proteins, BSA (lane 1), GO (lane 3) and
catalase (lane 6). The isoelectric points of GO, BSA, and catalase are 4.2, 4.7
and 5.4, respectively. Therefore, they are negatively charged at pH 7 and
migrate towards the positive electrode. The Prodots are also negatively
charged and migrated towards the positive electrode, however to a lesser
extent than their corresponding parent proteins due to their increased size
and/or decreased overall charge. The average pore size of the gel (0.5%
agarose used here) is ~450 nm230 and all Prodots readily migrated through
these pores. Furthermore, lanes 2, 4 and 7 do not indicate the presence of
unmodified proteins, and complete conversion is achieved.
The current method has a significant advantage over reported methods231
and it produced much smaller Prodots from several proteins for potential
bioimaging and protein delivery applications.

159

160

E

Figure 4.1 DLS profiles of pristine proteins (left panel) with corresponding Prodots
(right panel) (A) GO and nGO, (B) HRP and nHRP, (C) Lipase and nLipase, (D)
Catalase, and nCatalase. DLS of all the samples were measured with 0.2 mg/ml of
protein in 10 mM sodium phosphate buffer at pH 7, (E) Agarose gel (0.5%) of BSA
(lane 1), nBSA (lane 2), GO (lane 3), nGO (lane 4), Catalase (lane 6), nCatalase
(lane 7). Samples were spotted in the middle of the gel (shown as black rectangles)
and resolved with 10 mM Na2HPO4 buffer at pH 7
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4.4.3. Size and Shape of Prodots
Dynamic Light Scattering (DLS) and Transmission Electron Microscopy
(TEM) were used to examine the Prodots, their morphology, size and shape.
DLS is used to determine the hydrodynamic radius of the particles (Figure
4.1A-D) and compared with the sizes of the corresponding parent
protein/enzyme. Sizes of nGO, nHRP, nLipase and nCatalase were found to
be 15, 20, 50 and 50 nm, respectively. In contrast, enzyme particles prepared
by precipitation with salt solutions produced 5-50 µm particles, which are
unsuitable for a number of biological applications.
The DLS data are supported by the TEM images (Figure 4.2). An inset in
each panel shows the expanded view of a particle from each panel to clearly
depict their sizes and shapes. Panel A shows nGO particles with nearly
spherical shape having a diameter of 10-15 nm, whereas nHRP (panel B)
shows a distribution with most prominent particles of ~20 nm in size.
Nanoparticles of lipase had average size ~15 nm with a nearly uniform
distribution (panel C). The sizes of nGO and nHRP from the TEMs are
consistent with those from DLS, while nLipase indicated much higher size in
DLS than here, and this could be due to agglomeration due to strong
hydrophobicity of lipase.
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Figure 4.2 TEM images of protein nanoparticles (A) nGO (B) nHRP and (C) nLipase
after uranyl acetate staining. The size bar represents 100 nm, and the inset shows
the expanded view of one particle in each panel. The nanoparticle solution (0.2
mg/mL) in nano pure DI was applied to a carbon-coated Cu grid (400-mesh)
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4.4.4. Spectral Measurements and Fluorescence Quenching Studies
Emission

properties

of

Prodots

were

evaluated

by

fluorescence

spectroscopy. As shown in Figure Figure 4.3A, fluorescence intensity of FITC
bound to nanoparticles maintained more than 80% of initial emission except in
the case of nGO where the intensity decreased by nearly half. Emission
spectra corresponded to that of FITC and changes observed in emission
spectral shifts and intensities are presumably due to changes in the
chromophore environment as it is transferred from the aqueous phase to the
interior of the Prodots. This possibility was tested in fluorescence quenching
studies with potassium iodide (KI). Addition of iodide quenched FITC
fluorescence with a Stern-Volmer constant (Ksv) of 16 M-1 (Figure 4.3B, light
green line), whereas the corresponding Ksv values of the protdots were
significantly less (6 M-1, Figure 4.3B, dark green line). This decrease in Ksv
indicates that the fluorophore in Prodots is protected by the protein matrix,
likely due to its deep embedment within the nano particles. These data
indicate that the prdots are suitable for imaging studies.
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A

B

Figure 4.3 (A) Emission spectra of Prodots when compared to that of FITC. All the
spectra are normalized by dividing by their corresponding absorbances at 495 nm;
(B) Iodide quenching of FITC (light green) and FITC bound-nCatalase (dark green)
emission and analyzed by Stern-Volmer equation
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4.4.5. Protein Secondary Structure and Activity
The native structure of protein is vital for the retention of its biological
activity. The circular dichroism (CD) spectra of the Prodots were compared
with those of the corresponding free proteins to evaluate any distortions in the
secondary structures during/after the formation of the particles. The far UVCD spectrum showed a strong peak at 192 nm corresponding to '#sheets
and double minima at 209 and 222 nm, which are characteristic of the
!#helices (Table 4.2). These spectral profiles of Prodots nearly followed the
CD spectra of the corresponding free proteins, which indicated a significant
retention of the native-like secondary structures, even after the particle
formation (Figure 4.4A).
Table 4.2 Far UV CD intensities (m deg/µM.cm) of protein nanoparticles collected
with a 0.05 cm path length cuvette

Sample

222 nm

(Prodots/Protein)222

208 nm

222/208 nm

BSA

-65

1.0

-71

0.92

nBSA

-71

1.1

-76

0.93

GO

-36

1.0

-46

0.78

nGO

-44

1.2

-54

1.20

Catalase

-9.0

1.0

-21.0

2.30

nCatalase

-8.0

0.9

-24.0

3.00
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In addition to the CD arising from the protein structure, we also observed
induced CD (ICD) band for some of the Prodots, in the wavelength region
corresponding to the fluorescein absorption band. For example, nBSA
showed an ICD band at 550 nm, which is likely due to the interaction of the
fluorophore with the protein asymmetric environment surrounding it.
Therefore, close association of the chromophore and asymmetry of its
environment are clearly illustrated.
The retention of protein secondary structure in Prodots suggested the
possibility for the retention of their biological activities. Enzymatic assays were
performed and the specific rates were compared with those of the
corresponding free enzymes, under similar conditions of pH, buffer, ionic
strength and temperature. For example, the catalytic activity of nGO was
monitored by the catalytic oxidation of D-glucose to gluconic acid with ambient
oxygen, and the production of hydrogen peroxide was measured by its
reaction with guaiacol (substrate), catalyzed by HRP. Guaiacol oxidation
results in a colored product, whose formation was monitored by following its
absorption at 470 nm as a function of time (Figure 4.4B), as reported earlier.
Catalytic activity observed for nGO at 25 ºC is ~ 80% of the unmodified GO.
Extensive structure retention and facile diffusion of the substrate to the active
site are permitted in nGO.
The specific activities of Prodots with respect to the corresponding
unmodified enzymes (100%) are compared in Figure 4.4C, and these show
that nGO and nHRP retained significant activities (70-80%) while nlipase and
nCatalase indicated a significant drop in activity. Note that these two later
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examples formed much larger particles and drop in activity may be a direct
result of slower mass transfer through these larger particles. Thus, controlling
the size of the particles is critical in retaining the activities, in addition to
retaining the native-like structures. Next, we examined the stabilities of these
particles for practical considerations and particle nature might enhance the
stability by lowering the conformation entropy of the protein molecule.
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% Retention of Specific Activity
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nHRP
nCatalase
nLipase
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B
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0

Figure 4.4 (A) Far UV-CD of Prodots (solid lines) and those of their corresponding
parent proteins (dashed lines), (B) Kinetic traces showing enhanced oxidase activity
of nGO at 60 ˚C when compared to that of unbound GO (C) Bar graph showing the
percent retention of specific activities of protein nanoparticles with respect to those of
the parent proteins taken as 100%.
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4.4.6. Thermal and Storage Stabilities of Protein Nanoparticles
Prodots should have sufficient stability if their uses in biomedical
applications are to be realized. This aspect was assessed by differential
scanning calorimetry (DSC). DSC can provide direct measures of the
denaturation temperature (Td), enthalpy (∆H), heat capacity and entropy
changes, Both ∆H and Td are obtained in a model independent manner, even
when the denaturation is irreversible. DSC thermograms of Prodots, therefore,
were quantified and compared with those of the corresponding parent proteins
(Figure 4.5A-D, Table 4.3). For example, the DSC profile of nGO (Figure 4.5A,
solid line) indicated an endothermic transition at 70 ºC whereas GO (Figure
4.5A, dashed line) showed a transition at 63 ºC, which is significantly lower.
Similar improvement in Td was also observed for nBSA (Figure 4.5B, solid
line), 67 ºC for nBSA vs 60 ºC for BSA (Figure 4.5B, dashed line). However,
nHRP and nCatalase showed thermal stabilities similar to their pristine
proteins with the denaturation temperatures of 85 0C and 64 0C, respectively
but not any lower than their parents (Figure 4.5C,D).
In support of the above observations in the DSC of nGO, activities of the
heat-treated (60 ºC for 5 min and cooled for 1 h) nGO showed significant
retention (75%) when compared to that of GO (10%) when treated in a similar
manner (Figure 4.4B). In addition to thermal stability, one challenge with
proteins is their poor storage stability requiring storage at low temperatures or
deactivation at room temperatures. The Prodots are expected to have
improved storage stability due to the encasement of the protein within the
nano particles. The storage stabilities of Prodots (60 ºC in Na2HPO4 buffer at
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pH 7) were tested by taking aliquots of the samples, periodically, and
measuring their specific activities.
Table 4.3 Thermodynamic parameters ("H) and denaturation temperatures (Tm) and
Half-lives for the thermal denaturation of Prodots and those of the corresponding
parent proteins

"H (kcal/mol)

Tm (0C)

Half-life (min)

BSA

157 ± 24.7

60.0 ± 0.4

ND

nBSA

165 ± 10.8

67.0 ± 0.5

ND

GO

242 ± 13.0

63.5 ± 0.3

7

nGO

260.3 ± 0.6

70.7 ± 0.1

30

HRP

43.3 ± 1.0

84.0

420

nHRP

31.5 ± 0.5

85.3 ± 0.05

420

Catalase

358.4 ± 33.6

63.5 ± 0.7

15

nCatalase

400.5 ± 2.12

64.0

>120

Sample

To accelerate the aging of the samples, we chose to keep them at 60 ˚C,
as a benchmark, and compared the stabilities with those of the parent
proteins. Even though the samples were kept at 60 ˚C, the catalytic activities
were determined at room temperature, as described earlier, and the time
taken to decrease the original activity of the sample by 50% (storage half-life)
has been calculated from plots of activities vs storage time (Table 4.3). Halflife of nGO increased to 30 minutes at 60 ˚C, when compared to that of GO (7
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minutes). The nLipase half-life improved to 130 min at 60 ˚C when compared
to 15 minutes for lipase at the same temperature. Improved half-life at 60˚C
suggests that storage stabilities at room temperature are expected to be even
longer, based on the Arrhenius model for the thermal deactivation.
4.4.7. Cellular Imaging Studies
The goal of producing stable, fluorescent, functional Prodots is to test their
potential for biomedical applications such as cellular imaging. Cellular uptake
and release of Prodots were performed using oral cancer cells (HN12) which
have been extensively used for such studies.35 Confocal microscopic imaging
allowed us to analyze the uptake as well as the release of GO nanoparticles
with HN12 cells (Figure 4.6A-C). Incubation of HN12 cells with nGO for 4 h
showed that these were readily taken up into the cellular interior as indicated
by the green fluorescence (Figure 4.6A), after washing the cells with the
media to remove unbound or unabsorbed nano particles. Localization of this
fluorescent signal is clearly un-even in the cells with bright spots observed in
certain areas. Some cells were without any fluorescence signal characteristic
of nGO, which indicates a failure in the uptake of the Prodots by these cells.
This phenomenon is not unusual, since not all cancer cells are not expected
to be identical and some are distinguished from the others by certain
biological traits. Superposition of the fluorescence and transmission images
confirmed that the amount of nGO uptake is different from certain cells to the
others within the same culture.
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A

B

C

D

Figure 4.5 DSC thermograms of (A) nGO (solid line), free GO (dashed line) and (B)
nBSA (solid line), free BSA (dashed line) (C) nCatalase (solid line), free Catalase
(dashed line) and (D) nHRP (dashed line), free HRP (solid line)
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We analyzed the rates of internalization of nGO by live cells by using timelapse confocal microscopy by monitoring the emission intensity from particular
cells, as a function of time. Average fluorescent intensity from within the cells
suddenly increased after 2-2.5 h of the addition of nGO, which suggest that
the internalization has a lag phase (Figure 4.6 D). The intensity after 195 min
of addition differed among different cells within the same culture, which is due
to the differences in the uptake kinetics of each cell (Figure 4.6E).
Interestingly, the nanoparticle internalization was accompanied by significant
cell blebbing (vesicular out pocketing) of the plasma membrane, which may
be an indication of a transient permeabilization of the plasma membrane
caused by the nanoparticles.

174

A

C

B

D

E

Figure 4.6 Confocal micrographs of oral cancer cells taken after 4 h of incubation
with nGO, (A) green color is the emission from Prodots; (B) transmission micrograph
of the same region; and (C) Overlay of transmission and fluorescence images, scale
bar represents 50 µm. Quantification of time lapse, in-vivo imaging of nGO
internalization by HN12 cells. (D) The average intracellular fluorescence intensity of
10 cells, and (E) individual cells after addition of nGO, AU: arbitrary units
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In contrast, the nBSA sample was not readily internalized by HN12 cells
(Figure 4.7 A, B), however they were readily taken up when incubated along
with unlabeled nGO, without the FITC label. For example, incubation of oral
cancer cells with BSA nanoparticles did not show any internalization of these
particles and the internalization of nBSA was induced by the presence of nGO
(Figure 4.7C, D) in the medium. Since nGO was not labelled in these
experiments, the emission was solely from nBSA internalized into the cells. A
likely explanation for this observation is that the culture media used contained
glucose, which is a substrate for nGO. The byproduct of this reaction
produced

hydrogen

peroxide

(H2O2)

and

H2O2

induces

transient

permeabilization of cell membranes.232,233 thus, nGO assisted in the
internalization of nBSA, while nBSA itself is not taken up by the cells.
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A

B

C

D

Figure 4.7 Confocal micrographs of HN12 cells exposed to: (A) nBSA at 0 min and
(B) at 130 min showing the fluorescence out side the cells suggesting that nBSA is
not internalized over this time period. Confocal micrographs of nBSA + unlabelled
nGO at (C) 0 min and (D) 130 min showing that the nBSA are getting internalized in
the presence of nGO. Thus, nGO induced the internalization of nBSA. Each split view
shows the confocal fluorescence image (top left), bright field transmission image (top
right), overlay (bottom left)

177

To further test the role of nGO in the internalization of nano particles,
HN12 cells were incubated for two hours with nGO and dextran Texas red
(MW 10,000 Da), which is normally introduced into the cells by microinjection.
Internalization of both dextran Texas red and nGO occurred at the same time
scale, and internalization is accompanied by significant blebbing of the
plasma membrane, both of which indicated transient permeabilization of the
membrane by nGO (Figure 4.8). Note that none of the cells are killed by the
treatment with these nano particles, over this time period, and this could be
due to their biocompatibility.
Recent studies on kinetics of nanoparticles uptake by cells show that
uptake of Tat peptide conjugated QDs (Tat-QD) by HeLa cells takes place
slowly and complete accumulation is achieved only after 24 h.234 In another
study, to promote the uptake of AuNPs, they were conjugated with
oligonucleotides, which exhibited higher cellular uptake properties than
without the oligonucleotide.235 In addition, single-walled carbon nanotubes
(SWCNT), graphene oxide (GO) and carbon dots (C-dots) have also recently
been used as cellular imaging probes.236 For example C-dots are taken up by
human colon adenocarcinoma HT 29 cells only after overnight.237 Although
the semiconducting nanoparticles showed resistance to photo bleaching when
compared to the organic dyes, their cytotoxic effects are harmful to cells.238
Carbon based materials, on the other hand, are less toxic and photostable but
they show very slow kinetics of cellular internalization.239 In comparison to the
existing nano probes, the Prodots described here have specific advantages,
smaller size, higher stability while retaining their biological activities to a
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significant extent, and these are promising alternatives as biocompatible tools
for cellular imaging.
These studies also demonstrate that nGO facilitated the internalization of
nanoparticles, and these Prodots could be potential carries for the delivery of
small-molecule drugs, proteins or other bioactive molecules.
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Figure 4.8 Confocal micrographs of HN12 cells incubated with nGO-FITC (0.5mg/ml,
green) and Dextran Texas Red (0.5mg/ml, MW 10000 Catalog#D1863, Invitrogen)
for 2 h. Internalization of both dextran and nGO seems to occur both at the same
time and is accompanied by significant blebbing of the plasma membrane, both of
which indicates transient permeabilization of the membrane
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4.5. Conclusions
We have successfully developed a simple and effective approach to
synthesize purely protein-based nanoparticles in the size range of 15-20 nm,
which falls under the optimum size category for a number of cell based
studies. Due to their inherent biocompatibility and biodegradability together
with low toxicity, Prodots are positioned as multitasking bright materials when
compared to any other existing nanomaterials, such as QDs or semiconductor
NPs. In addition to their preserved biological activities, Prodots showed
improved half-life and enhanced thermal stabilities when compared to their
corresponding free proteins. These improved properties of Prodots may
facilitate their use in protein delivery, sustained release or advanced
biocatalysis. Most other systems are lacking in many desired properties due
to the alterations of protein structure during the nanoparticle synthesis and
formulations. Most importantly, the fact that these are rapidly internalized into
cancer cells, in the presence of glucose oxidase, will be of an advantage for
cellular imaging and protein transduction studies.
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